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PREFACE 
This research program stems from questions generated while using soft tissue 
manipulation techniques as a clinician. Of particular interest was instrument-assisted soft 
tissue mobilization (IASTM). My intrigue grew as to how this form of manual therapy 
resulted in the positive effects seen during the treatment of a variety of disorders 
involving connective tissue dysfunction, e.g. ligament sprains, tendons strain, posture 
imbalances, repetitive strain injuries and myofascial pain syndromes. 
 A specific type of IASTM, i.e. instrument-assisted cross fiber massage (IACFM), 
and connective tissue type, i.e. ligament, were focused on during this dissertation in 
order to narrow the scope of study. The primary purpose was to gain a better 
understanding of the tissue level effects of this treatment modality on ligament healing.   
Preliminary studies in this dissertation provide support for the use of IACFM in 
the treatment of ligament injury. These findings are pertinent given the current health 
care climate of evidence-based practice and an aging population. However, it is just a 
beginning. It is a goal that this line of research continues on both a basic science and 
clinical level. Greater insight into how mechanical forces applied to the surface of the 
body are transduced into a beneficial response will help lead to optimal therapeutic 
outcomes. 
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ABSTRACT 
 
Mary T. Loghmani 
 
THE EFFECTS OF INSTRUMENT-ASSISTED CROSS FIBER MASSAGE 
 ON LIGAMENT HEALING 
Ligament injury is one of the most prevalent musculoskeletal disorders that may 
lead to disability or disease, such as osteoarthritis. Conservative interventions which 
accelerate or augment ligament healing are needed to enhance therapeutic outcomes. 
The purpose of this research agenda was to investigate the tissue level effects of a type 
of manual therapy, cross fiber massage (CFM), in particular instrument-assisted CFM 
(IACFM), on ligament healing. 
Bilateral knee medial collateral ligament (MCL) injuries were created using an 
established rodent model where one MCL received IACFM treatment and the other 
untreated MCL served as a within subjects control. The short and long term effects of 
IACFM on the biomechanical and histological properties of repairing ligaments were 
investigated. Tensile mechanical testing was performed to determine ligament 
mechanical properties. Ligament histology was examined under light microscopy and 
scanning electron microscopy. IACFM was found to accelerate early ligament healing (4 
weeks post-injury), possibly via favorable effects on collagen formation and organization, 
but minimal improvement was demonstrated in later healing (12 weeks post-injury).  
 Regional blood flow and angiogenesis were investigated as possible 
mechanisms underlying the accelerated healing found in IACFM-treated ligaments. 
Laser Doppler perfusion imaging was used to investigate vascular function. Micro-
computed tomography was used to determine vascular structural parameters.  
Compared to untreated contralateral injured controls, IACFM-treated injured knees 
demonstrated a delayed increase in blood flow and altered microvascular structure, 
possibly suggesting angiogenesis. 
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Mechanotransduction is a proposed mechanism for the beneficial effects of CFM 
in that application of a mechanical force was found to enhance biomechanical and 
histological properties as well as vascular function and structure acutely in healing 
ligaments. Although this thesis focused on IACFM treatment of injured knee ligaments, it 
is plausible for concepts to apply to other manual modalities that offer conservative 
alternatives to invasive procedures or pharmaceuticals in the treatment of soft tissue 
injuries.    
 
Stuart J. Warden, PT, Ph.D., Chair  
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CHAPTER ONE 
Introduction 
Thesis Overview 
Ligament injuries are common disorders treated by clinicians. Soft tissue 
mobilization (STM) is a form of manual therapy frequently used in the conservative 
management of such musculoskeletal disorders. It is known that ligament cells are 
mechanosensitive to their environment. Massage is a form of STM that may have the 
potential to influence ligament healing since it provides a form of mechanical stimulation. 
This research program focuses on the effects of a type of massage, cross fiber massage 
(CFM), specifically instrument-assisted cross fiber massage (IACFM), on ligament 
healing. The findings of studies investigating the tissue level effects of IACFM on 
biomechanical and histological properties, and vascular function and structural 
parameters in injured knee ligaments in an animal model are reported in this 
dissertation. The dissertation outline is as follows: 
 
Chapter One provides pertinent background information and proposes the general aims 
of this research agenda. It is organized into two primary parts.  
  
Part A discusses the anatomy, biomechanics and physiology of a type of 
connective tissue, i.e. ligaments. The adaptation of connective tissues to load and 
the healing and repair process are also reviewed.  
  
Part B discusses a type of massage, CFM, specifically IACFM, in the context of 
different manual therapy approaches and provides preliminary evidence supporting 
its application. Finally, the general aims of this research project are summarized.  
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Chapter Two describes the methodology used in the first set of studies investigating the 
short and long term effects of IACFM on the biomechanical and histological properties in 
healing knee ligaments in a rodent model. Tensile mechanical testing was performed at 
4 and 12 weeks post-injury to determine ligament mechanical properties. Ligament 
histology was also examined under light microscopy at 4 and 12 weeks. Scanning 
electron microscopy (SEM) was performed to further determine ligament microscopic 
morphology at 4 weeks. 
 
Chapter Three outlines the methodology for the second set of studies in this research 
agenda. Laser Doppler perfusion imaging (LDI) was used to investigate regional blood 
flow at 4 weeks post-injury. Subsequently, vascular structural parameters were 
determined by using micro-computed tomography (micro-CT) to explore angiogenesis as 
a possible underlying mechanism for IACFM effects. 
 
Chapter Four provides a conceptual introduction to mechanotransduction as an 
underlying mechanism for the therapeutic effects of IACFM. Clinical implications are 
considered. 
 
Chapter Five summarizes the findings of studies in this research project. Limitations and 
future directions are also discussed.   
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Part A: Ligament anatomy, biomechanics and physiology 
 
1.1 Introduction 
 
1.1.1 Overview 
 
The musculoskeletal system is composed of bone, tendons, ligaments, and 
muscles. Connective tissue is ubiquitous and pervades the body systems. Ligaments are 
a type of connective tissue characterized by a dense, parallel fiber alignment. They 
support joint structures, attaching bone to bone. Ligaments function best under tensile 
load due to their fiber alignment, and serve to transfer load along their longitudinal 
direction (axis).1 Ligament cells are mechanosensitive and appropriate mechanical force 
is critical for normal ligament development, growth, and healing and repair. On the other 
hand, ligaments are vulnerable to injury with loads exceeding their tensile limits. There is 
a need for conservative interventions to address the short- and long-term consequences 
of ligament injuries.   
 
1.1.2 Ligament injury  
 
 Ligament injury (sprains) lead acutely to pain and functional limitations, and 
because of resultant imbalances in joint mobility and stability, can lead chronically to 
disability, permanent joint dysfunction, susceptibility to re-injury2-4 and disease, such as 
osteoarthritis.5 Extra-capsular and capsular ligaments heal by reparative scar versus 
regeneration. As a result, persistent tissue weakness and neuromuscular deficiencies 
may explain why a history of ligament injury is a strong risk factor for subsequent injury.     
In fact, patients may continue to experience significant symptoms for years following 
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ligament injury.2-3, 6-7 The eventual goal of ligament healing is to fully restore its 
biomechanical properties so that it can appropriately guide and stabilize the joint‘s 
position and motion during static and dynamic functional activities. Accelerated tissue-
level healing may allow individuals to return to function more quickly with less risk of re-
injury, while augmented healing may restore the tissue to its full capacity, potentially 
preventing degenerative disease. 
 
1.1.3 Epidemiology of ligament injury 
 
Musculoskeletal conditions are the third most common reason for physician office 
visits, second only to respiratory and neurological system disorders,8-9 with injury being 
the most costly disease annually.10 Musculoskeletal conditions are the leading cause of 
disability, affecting 7% of the U.S. population on an annual basis. Unfortunately, the 
economic burden of musculoskeletal disease is expected to escalate over the next two 
decades due to an aging population.11 Within the musculoskeletal system, ligament 
injuries are prevalent disorders, accounting for approximately 50% of athletic injuries, 
with nearly 90% of knee ligament injuries involving the anterior cruciate ligament (ACL) 
and medial collateral ligament (MCL).1, 6, 12-14 Interventions for injured ligaments that 
facilitate early recovery (i.e. accelerate healing) and/or enhance final outcomes (i.e. 
augment healing) are needed.  
 
1.1.4 Current interventions for ligament injury 
 
Conservative treatments and surgical repair have demonstrated similar 
outcomes, regardless of the initial ligament damage (i.e. partial and full thickness 
ligament tears).15-17 Several clinical alternatives to surgical ligament repair have been 
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investigated with positive effects, such as therapeutic laser,18 direct current19 and low-
intensity ultrasound.20-22 Other studies investigating the use of gene therapies, growth 
factors, biological scaffolds, and stem cell therapies have shown some promise in 
influencing ligament healing.23-26 However, these techniques are costly and not readily 
available. Currently, there are no interventions with established clinical efficacy and 
acceptance in accelerating or augmenting ligament healing.27 There remains a need to 
establish readily available, cost effective interventions that facilitate achievement of short 
and long term recovery goals from ligament injury. Manual therapies that offer 
conservative alternatives in the management of musculoskeletal conditions warrant 
further investigation towards the end goal of improving therapeutic outcomes. 
 
1.2 Connective tissue overview 
 
1.2.1 Connective tissue organization  
 
Soft tissues of the body include connective tissue structures (i.e. tendons, 
ligaments, fascia, fibrous tissues, fat, and synovial membranes), muscles, nerves and 
blood vessels.28 Beside primary connective tissue (a.k.a. connective tissue proper, 
ordinary connective tissue, supporting tissue), there are other specialized connective 
tissues: adipose (fat), bone, cartilage, myeloid and blood. Primary connective tissue 
originates from mesoderm, and does much more than serve to connect and provide 
structural support to structures/organs of the body. It surrounds other basic tissue types, 
i.e. muscle, nerve and endothelium, and acts as a reservoir for ion and water storage.  
Connective tissue functions as a physical defense barrier to infectious organisms, 
helping to mediate immunity, inflammation and repair. Furthermore, connective tissue 
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contains blood vessels and thereby supports the transport of nutrients, metabolites and 
waste products between tissues and the circulatory system.28-29 
Primary connective tissue has been classified as ‗dense, regular‘ (e.g. ligaments, 
tendons), ‗dense, irregular‘ (e.g. joint and organ capsules, dermis, aponeuroses) or 
‗loose irregular‘ (a.k.a. areolar) (e.g. subcutaneous fascia, epithelial linings). In reality, 
there is a continuum of connective tissue fiber arrangements that exhibit the appropriate 
organizational structure to provide the required mechanical support. All connective 
tissues are composed of cells in an extracellular matrix (ECM). The ECM mostly consists 
of fibers in ground substance. The ground substance is composed mainly of 
glycosaminoglycans (GAGs), proteoglycans, structural glycoproteins and water.28-30   
 
1.2.2 Connective tissue cells 
 
Diverse cell populations are interspersed throughout connective tissue, each with 
different origins and functions (Table 1.1). Fibroblasts are the principal cell type in 
ligament. They are derived from mesenchyme and are relatively few in number, 
representing a small portion of total ligament volume. Fibroblast sparseness combined 
with low mitotic activity leads to a relatively low tissue turnover rate, and may be a factor 
in the inherently poor capacity for ligament healing.31 Fibroblasts are spindle-shaped 
cells which align along the long axis of the ligament. They have cytoplasmic extensions, 
which may allow for cell-cell communication in coordinating cellular and metabolic 
responses in the tissue. Fibroblasts perform anabolic and catabolic functions in the 
synthesis and maintenance of the surrounding connective tissue matrix, compared to 
bone which has two cell types, i.e. osteoblasts and osteoclasts, which form and absorb 
bone respectively. Fibroblasts not only produce ECM components (e.g. collagen) and 
factors that influence growth and differentiation (e.g. TGF-β); they also produce matrix 
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metalloproteinases (MMPs) (e.g. collagenase) responsible for ECM degradation. MMPs 
play an important role in tissue remodeling associated with various processes such as 
angiogenesis, tissue repair, and disease. Of significance, fibroblasts synthesize proteins 
that form ECM fibers and ground substance.32-34 
 
Table 1.1 Summary of connective tissue cell types, origins and functions* 
Cell Type Origin Function 
Fibroblast, 
osteoblast, 
chondroblast 
Mesenchyme Produce fibers and ground substance of primary 
connective tissue, and specialized connective tissues, 
i.e. bone and cartilage  
Osteoclast Hematopoietic Removes bone tissue 
Adipose Mesenchyme Stores energy and heat  
Myofibroblast Mesenchyme Assists with wound contracture and scar formation 
Macrophage Hematopoietic Phagocytosis, cytokine secretion 
Mast Hematopoietic Participates in allergic reactions, e.g. histamine release 
Plasma cells Hematopoietic  Immunological response; Produces antibodies 
Lymphocyte  Hematopoietic Immunological response 
Leukocytes Hematopoietic Immunological response; Participates in phagocytosis  
*Adapted from Junqueira, L. C. and J. Carneiro (2005). Basic Histology.
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1.2.3 Extracellular matrix fibers 
 
Fibroblasts synthesize the two main types of fibrillar proteins found in connective 
tissue, i.e. collagen and elastin. Collagen is the most abundant protein in the human 
body and the major structural component of ligament ECM. There are 29 different types 
of collagens described thus far. Two-thirds of ligament weight is water, but three-
quarters of their dry mass is made of collagen. Collagen type I predominates 
(approximately 90% of ligament dry weight) followed by collagen type III (approximately 
8% of ligament dry weight). Collagen type III is an immature form of collagen and is 
mechanically inferior compared to collagen type I, the latter of which has the tensile 
strength of steel. The collagen type I to type III ratio within a healing ligament represents 
the relative maturity of collagen present. In contrast, elastin is a structural protein that 
confers elastic recoil and stretching properties to the ECM.35 
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Collagen type I is organized hierarchally into fibrils, fibers, fiber bundles and 
fascicles that align in the direction of tensile forces.36 Collagen synthesis begins in the 
fibroblast and is completed in the ECM. Amino acids (i.e. glycine 33.5%, proline 12%, 
hydroxyproline 10%) are used to synthesize three polypeptide α chains (two α1 and one 
α2 peptide chains) referred to as preprocollagen, on the polyribosomes of the cell‘s 
rough endoplasmic reticulum (RER). The amino acid sequence follows a repeating 
pattern. Each α chain is synthesized with a signal peptide and an extra length of terminal 
peptides called registration peptides, the latter of which assist in appropriate α chain 
positioning during procollagen assembly and prevention of intracellular aggregation of 
the molecules. Once the signal peptide is clipped in the lumen of the RER, the three α 
chains assemble into procollagen (a collagen precursor). Lysine and proline residues on 
the polypeptide chains are hydroxylated in the RER lumen. Hydoxylated amino acids 
(i.e. 3- and 4-hydoxyproline) are essential for formation of collagen cross-links.  
Procollagen is shipped to the Golgi apparatus where it is packaged and transported to 
the cell surface in vesicles and exocytosed. Once in the ECM, procollagen is converted 
to tropocollagen after the registration peptides are removed due to contact with 
extracellular substances (i.e. peptidase, GAGs). Tropocollagen, is comprised of the 
three polypeptide α-chains forming a triple-stranded, helical molecule (280 nm length; 
1.5 nm width). The hydroxyproline residues help stabilize the tropocollagen triple helix by 
forming hydrogen bonds between the polypeptide chains. Tropocollagen molecules 
polymerize outside the cell in a quarter staggered head-to-tail formation to form fibrils 
(50-200nm diameter). The displacement of adjacent tropocollagen molecules in the fibril 
creates the characteristic periodicity of striations (64 nm wide) when stained for electron 
microscopy. ECM proteoglycans and structural glycoproteins play an important role in 
the spontaneous aggregation of the fibrils into collagen fibers.  
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During the final stages of collagen maturation, the fibrillar structure is 
mechanically stabilized by covalent cross-link formation between tropocollagen 
molecules.37 The mature, non-reducible cross-link hydroxylysyl pyridinoline is important 
to improving ECM strength and tissue quality in healing ligaments.29, 38-39 Collagen type I 
fiber organization, cross-links and diameter modulate tissue tensile strength and 
stiffness. For instance, fibril diameters in injured ligaments are smaller than in non-
injured ligaments, and diameters increase as ligament mechanical properties increase 
during healing.40 Ligament mechanical properties are influenced by other, non-
collagenous proteins found in the ECM ground substance.28-29  
 
1.2.4 Extracellular matrix ground substance 
 
The ground substance fills connective tissue space not occupied by fibers or 
cells. It is formed mostly from GAGs (a.k.a. mucopolysaccharides) (approximately 0.5% 
of ligament dry weight) and water. GAGs are long, linear, poly-disaccharides that attach 
to a protein core to form proteoglycans (a.k.a mucoproteins). Despite its minor mass, 
GAGs play an important functional role in the matrix. The negative (acidic) charge of the 
GAGs repel each other, creating a voluminous bottlebrush-like structure that attracts 
water which causes the proteoglycans to swell and trap fluid between the collagen 
fibers. This hydrates the structure and contributes to its compressive strength. The huge 
proteoglycan molecules are electrostatically attracted to each other and the surrounding 
water creating a flexible, semi-fluid gel that allows rapid diffusion of water-soluble 
metabolites.35, 41-42 Proper hydration of the ECM is important to cell function and 
viscoelastic behavior in ligaments.41-42 Proteoglycans also influence the rate and 
organization of collagen fibrils during ligament healing.32, 43  
10 
 
Structural glycoproteins help to mediate the interactions of cells and other ECM 
constituents. They are made of protein chains bound to branched polysaccharides that 
function as links between the ECM and cells; binding to cells, collagen, GAGs, 
proteoglycans and other glycoproteins. Fibrillin and fibronectin are examples of fiber-
forming glycoproteins, while laminin, entactin and tenascin are non-filamentous forms.  
Glycoproteins influence the mechanical properties of tissue as well. For example, 
fibronectin provides for stability and cell-ECM communication by binding to collagen in 
the ECM and integrins in cell membranes, thereby linking actin filaments of the 
cytoskeleton to in the ECM.31, 36 Ligaments are primary connective tissue type structures. 
 
1.3 Ligament anatomy and histology  
 
Ligaments and tendons have similar fibrous connective tissue organization 
characterized by dense, regularly arranged fibers. In general, ligaments attach bone to 
bone while tendons attach muscle to bone. There are two major ligament subgroups:  
skeletal and suspensory. Skeletal ligaments may be extra-capsular/capsular (i.e. knee 
MCL) or intra-capsular (i.e. knee ACL) and can serve many functions, including 
stabilizing joints, maintaining skeletal alignment, guiding joint motion, providing 
proprioceptive input. Suspensory ligaments primarily support internal organs.39 Tendon 
collagen fiber bundles are aligned parallel to each other in line of a muscle‘s pull. In 
subtle contrast, ligament fiber bundles are roughly parallel, but may have oblique or 
spiral arrangements; the geometry being influenced by each ligament‘s adaptation to its 
specific joint restraining function. 
Ligament histology reveals a hierarchal organization of fibrils, fibers, primary fiber 
bundles, fascicles and whole structure. Ligaments have a crimped, waveform 
appearance along their long axis. The periodicity and size of the waves depends on the 
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specific structure and can change along the length of the ligament. The crimping pattern 
can be observed under light microscopy in the collagen fibril, which unfolds during initial 
collagen loading and allows the ligament to elongate without damage. A fiber (1-12 μm 
diameter) is a bundle of parallel fibrils. Fibers often appear wavy and appear to run the 
entire length of mature ligament.44 A primary fiber bundle is a collection of fibers. The 
diameter of the fiber bundle varies with the size of the tissue structure. Groups of 
primary fiber bundles form fascicles. It is the alignment (arrangement) of the fascicles 
and their fibers that affects the mechanical response of the tissue. Fascicles are typically 
arranged in a parallel manner in line with the ligament long axis. The ligament proper is 
formed from groups of collagen fascicles.31, 35-36 Ligaments insert into bone by a gradual 
transition from ligament to fibrocartilage to mineralized fibrocartilage to bone (i.e. 
insertional zones).28 
 
1.4 Ligament biomechanics 
 
1.4.1 Ligament biomechanics overview 
 
 Skeletal ligaments are anisotropic, i.e. being oriented to resist tension in an uni-
directional manner along their long axis; and, they possess time- and history-dependent 
viscoelastic properties. Thus, ligaments display nonlinear mechanical behavior during in 
vitro testing under tensile loading. Reasons for this nonlinear behavior are multifactorial: 
a) during stretching an increasing number of ligament fibers are recruited into tension, b) 
the crimp pattern slowly and progressively straightens (uncrimps), and c) fiber alignment 
improves.35 The nonlinear loading behavior in ligament matrix allows for some joint 
displacement to occur with relatively little effort, but provides increasing resistance as 
deformation increases. The mechanical behavior of ligaments also depends to some 
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degree on the environment, i.e. temperature, loading conditions such as strain-rate, and 
subject age and sex.14, 35, 39 
 
1.4.2 Material and structural properties 
 
As with most structures, the strength of ligament is influenced by the inherent 
properties of its constituents (material properties) and the way in which these 
constituents are arranged and interact (structural properties). In other words, the 
material properties of ligament are defined by its tissue-level qualities which are 
independent of structure or geometry. Material properties influence but cannot predict 
the behavior of the whole tissue, since the tissue as a whole is anisotropic and 
heterogeneous, and changes in its three dimensional (3D), structural geometry affect 
ligament mechanical properties.39 For example, ligaments with larger, cross-sectional 
areas require more force to failure than smaller ligaments. Also, the longer the ligament, 
the more deformation required to produce a force change comparable to shorter tissue. 
Additionally, the orientation of the ligament relative to its joint will affect its mechanical 
behavior. Although mathematical models have been developed to characterize the 
mechanical behavior of collagenous tissues, mechanical tests are needed to determine 
ligament mechanical properties.39 
 
1.4.3 Assessment of ligament biomechanical properties  
 
Since ligaments resist tensile forces, the mechanical properties of ligaments are 
normally determined by tensile tests, often using bone-ligament-bone complexes, where 
the tissue is displaced to tensile failure at a pre-determined rate while the changes in 
force are recorded. Structural biomechanical properties are typically derived from the 
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force-displacement curve (a.k.a. load-displacement, force-elongation curve) including 
ultimate force (maximum load) which is the peak or apex of curve on y-axis, stiffness 
(slope of linear portion of curve), and energy to failure (area under the curve). The initial, 
concave portion of the curve, the ―toe‖ region, is thought to be related to structural 
changes in fibril organization from a crimped pattern to a more straightened, parallel 
arrangement. In this region, initially little force (low load) is needed to elongate the 
tissue. During the linear portion of the curve fibers are parallel and lose their crimped 
pattern. Up to the end of this region, the structure produces an elastic response, in which 
unloading restores the tissue to its original length. At the end of the linear region, small 
force reductions may be observed in the curve for whole ligaments, possibly due to 
sequential failure of a few greatly stretch fiber bundles. At the end of the linear region, an 
endpoint is reached signifying the first major failure of fiber bundles, beyond which 
additional fiber failures occur in an unpredictable manner. Complete failure occurs once 
maximum load is obtained (Figure 1.1).45 
 
 
 
 
 
 
Figure 1.1. Representative force-displacement curve for a rodent knee MCL 
tensile mechanical test.  Properties that can be derived from the curve include 
ultimate force (peak on the curve on the y-axis) (N), stiffness (slope of the linear 
portion of the curve) (N/mm) and energy absorbed prior to failure (area under the 
curve) (mJ). 
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To account for structural variances, the load-deformation curve may be adjusted 
by dividing the force by the original cross-sectional area (tensile stress), and deformation 
by initial length (tensile strain). The resulting stress-strain curve provides mechanical 
(material) parameters of the collagen that are independent of tissue dimensions. 
However, stress-strain curves are often not used experimentally in bone-ligament-bone 
preparations due to challenges in the means to assess the cross-sectional area and 
length of ligaments during dynamic tensile testing in a practical and precise manner.39, 46 
 
1.4.4 Models of ligament injuries used for biomechanical assessment 
 
A ligament sprain is defined as an acute injury to a ligament. Clinically, more than 
85% are sub-failure injuries (Grade I and II are sub-failure injuries; Grade III is a 
complete failure injury). Ideally, a ligament injury model would re-create the diffuse and 
extensive nature of a clinical sprain; however, these types of injuries are difficult to 
consistently reproduce and quantify experimentally.47 Ligament injuries have been 
created by mid-substance scalpel cuts or wire rupture/pulls. The latter method causes 
more extensive damage, creating larger gap injuries.6 This is relevant, in that injury size 
affects healing, i.e. larger injuries show inferior structural properties at all healing 
intervals.48 Ligament transection injuries are commonly used for complete ligament 
disruption.49 Although surgical transection is not a perfect simulation of clinical injuries, it 
allows for controllable, reproducible injuries in size, pattern, and location.50 Mid-
substance ligament injuries are usually created since injury location has also been found 
to affect healing with injuries at either bony end tending to heal more slowly.51 The 
prevalence of MCL injuries and its propensity to spontaneously heal without surgical 
repair makes it a useful experimental model of ligament healing.1, 7  
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1.5 Ligament healing and repair process 
 
 Injured ligaments go through overlapping phases of healing: inflammation, repair 
and remodeling.52 Invariably, each stage entails a complex sequence of physiological 
and cellular events. The inflammatory phase is marked by vasodilation, increased 
vascular permeability, hemorrhage and clot formation. It begins immediately upon injury 
and lasts around 72 hours. The ECM in the injured area is highly disorganized with 
numerous inflammatory cells (e.g. phagocytes) infiltrating the area. The repair phase 
lasts from 72 hours until approximately 6 weeks in ligaments and is characterized by 
fibroblast proliferation, activation and matrix production. During this stage, fibroblasts 
appear plump and more numerous and disorganized ECM forms a scar that bridges 
between the torn fiber ends. However, the scar matrix gradually becomes organized and 
shifts from collagen type III to type I.14, 53 The remodeling phase is marked by improved 
collagen fiber alignment and increased collagen matrix maturation which can continue 
for years.14, 53-55  
The MCL heals spontaneously. In fact, long term results indicate surgical 
intervention results are not superior to conservative management of MCL healing in 
animals7, 21, 56-57 or humans.58-60 In contrast, ACL injuries show very poor recovery of 
function and typically require surgical repair.1, 6-7, 55, 57, 61-62 Subsequently, functional 
outcomes of MCL injuries are superior to ACL tears.63 Nonetheless, the MCL heals with 
grossly visible scar comparable to wound healing, that has altered ultra-structure and 
biochemical composition from normal.  
Ligament healing is affected by a number of factors; however, it requires 
adequate blood flow into the region for the transport of cells and metabolites.14, 55, 63 The 
greater capacity of the MCL to heal compared to other knee ligaments, may relate to its 
vascular anatomy.53  
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1.6 Ligament vascularity 
 
1.6.1 Ligament vascular anatomy  
 
Uninjured ligaments and tendons are typically hypovascular compared to other 
tissue, hence their whitish color. Ligaments contain sparse but distinctly organized 
microvascular distribution patterns. Blood vessels in ligaments play more than a nutritive 
role. They help maintain water content, excavate plasma components during 
inflammation, and regulate fluid and electrolyte balance in the ECM. Furthermore, the 
abundant association of nerves with blood vessels in ligaments may have several 
implications including proprioception, neuromodulation of blood flow under various 
condition such as growth and development, joint motion, inflammation and repair, 
maintenance of tissue metabolic demands, and local temperature regulation.41 
Gross dissection has demonstrated predictable patterns of blood supply to the 
different ligaments of the knee.64 In general, the key sources of blood supply to the MCL 
and lateral collateral ligament (LCL) are the superior and inferior geniculate arteries, 
while the middle geniculate artery is the primary source for the ACL.41, 64 The MCL has a 
relatively greater vascular supply, followed by the LCL, then the ACL.41, 64 Blood supply 
patterns may be related to the different healing capacities of the knee ligaments. For 
example, the ACL has a very limited number of vessels in its central portion which helps 
to explain its comparatively deficient healing ability.42  
Ligaments have an epiligamentous covering defined as any surrounding 
adherent connective tissue removed simultaneously with the ligament but grossly 
distinguishable from the ligament tissue proper. It is a more vascular layer on the 
ligament surface housing a vascular plexus containing a relative abundance of 
branching and anastomotic blood vessels.41, 65 Generally, the epiligamentous tissue 
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merges with the periosteum at the ligament attachment sites where it is also thicker and 
has a denser distribution of vessels. This covering contains more sensory and 
proprioceptive nerve endings than the ligament proper.66 Nerves tend to travel in close 
proximity with blood vessels and thus, also lie closer to the insertion sites. Tendons have 
a similar covering, suggesting loose connective tissue adjacent to ligaments and 
tendons contain an important source of vessels that eventually penetrate these 
structures and give rise to intra-ligament vessels.4, 41 The MCL epiligament is variable in 
thickness but covers the entire surface of the ligament at the microscopic level, while its 
joint surface aspect is continuous with the synovial membrane. It is well vascularized 
with some vessels penetrating the ligament‘s mid-substance, as compared to the ACL 
epiligament which is less vascular with few vessels penetrating the ligament proper.36   
Intra-ligamentous vessels are typically distributed sparsely within the ligament 
proper. In fact, one study using microspheres found vessels in the epiligamentous tissue 
surrounding ligaments receive approximately 75% of blood flow compared to only 25% 
going to the ligament proper.42 The vessels within ligaments appear to run in an 
organized manner parallel with the collagen fiber bundles of the densely organized ECM. 
Large areas of tissue within the ligament may remain devoid of vessels resulting in 
avascular areas that rely on diffusional pathways for oxygen and nutrients.41  
 
1.6.2 Ligament vascular physiology 
 
Injured ligaments demonstrate altered vascular dynamics that may be related to 
the healing response. Blood flow increases dramatically following injury during early 
ligament healing and stabilizes to near normal levels between 6-17 weeks. Blood flow 
and vascular volume increase with injury in both the ACL and MCL, but the responses 
are significantly amplified in the MCL and may be a prime factor in its superior healing 
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potential. 42, 53, 63 Nonetheless, a functional blood supply via an adequate tissue blood 
vessel network is critical for function in all ligaments. An appropriate therapeutic stimulus 
during all phases ligament healing would neither promote excessive blood vessel 
formation (i.e. angiogenesis) associated with a chronic inflammatory state or provide an 
inadequate stimulus that leads to a poor supply (ischemia), a small blood vessel 
network, or interruption of nascent blood vessels and granulation buds.67 In summary, 
increased tissue blood flow and angiogenesis plays an important role in all phases of 
ligament healing.   
 
1.6.2.1 Blood flow 
 
Blood flow is defined as the movement of blood in the cardiovascular system. 
The homeostatic health and function of tissues relies upon adequate perfusion of 
capillary beds, for nutrient and oxygen delivery from arterial blood and waste removal by 
the venous system. Furthermore, blood flow affects, in part, how tissues remodel and 
repair in adaptive response to changing stresses. Blood flow to articular connective 
tissue is comparatively much less than to other organ tissues, but adequate supply 
remains essential for normal tissue function. Ligament injury is considered a potent 
stimulus for increasing blood flow to and neo-vascularization of this tissue type.42  
 
1.6.2.2 Angiogenesis 
 
Angiogenesis is a process of neovascularization in which new blood vessels are 
formed from preexisting ones to meet the demands of tissue development and repair. 
Increased angiogenesis occurs with inflammation and wound healing.4 The process of 
vascular growth can occur via the sprouting of new capillaries from pre-existing vessels 
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or by intussusception and longitudinal division (angiogenesis), or dilation and remodeling 
of preexisting arterioles (arteriogenesis). The term arteriogenesis is used to describe the 
process of arteries acquiring smooth muscle and viscoelastic and vasomotor 
characteristics, or to refer to collateral growth from preexisting arteries.68-69 Angiogenesis 
should be distinguished from vasculogenesis, or ‗de novo‘ blood vessel formation, which 
is typically associated with the initial events during embryonic, fetal and neonatal vessel 
development involving primary vessel formation.68, 70-71 
 Angiogenesis in adult pathological conditions involves a complex sequence of 
events that signals and permits endothelial cells proliferation and migration which 
assemble, form cords and acquire lumens. Effective growth, development and long term 
survival of endothelium into a three-dimensional blood vessel network that meets the 
local functional demands requires a process that is tightly regulated by genetic, 
environmental and angiogenic factors, and multiple integrins affecting a variety of cell 
types and tissues.68, 72 Eventually, peri-endothelial cells (pericytes in small vessels and 
smooth muscle cells in larger vessels) migrate the length of sprouting vessels as they 
elongate and surround the nascent blood vessels. Peri-endothelial cells are markers for 
more mature blood vessels, and help to stabilize the vessels by inhibiting endothelial cell 
proliferation and migration. 
 
1.6.3 Assessment of vascular properties in ligament 
 
1.6.3.1 Assessment of blood flow  
 
Blood flow can be determined by a variety of techniques, e.g. microangiogram,73 
radio-active or colored microspheres,42 contrast-enhanced ultrasound,74 magnetic 
resonance angiography;75 all of which may require invasive procedures. Several 
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methods use optical techniques that rely on the Doppler shift effect, including laser 
Doppler flowmetry (LDF) and laser Doppler perfusion imaging (LDI), used for in vivo 
studies of tissue perfusion. The Doppler shift, named after Johann Christian Doppler in 
1843, is defined as the change in frequency and wavelength of a wave that is perceived 
by an observer moving relative to the source of the waves.76  
LDF is useful in monitoring temporal variations in blood flow and dynamic 
responses to a stimulus at a specific site. However, this method is not useful for 
quantitative diagnostics measures since it involves single point measurements (typically 
≤ 1 mm3) which assess only a small fraction of the entire tissue microvasculature, and 
requires direct tissue contact. Consequently, LDF findings are affected by the 
heterogeneity of the tissue, and are highly sensitive to probe location placement 
resulting in measurements that cannot be used for comparison studies.77 Comparatively, 
LDI does not require tissue contact since it uses a laser beam to scan several points 
across a tissue surface. 
LDI has been used to assess blood flow in a variety of tissues and conditions,4, 77-
82 including ligament perfusion, 42, 77 and the influence of blood flow on tissue healing.79 
LDI findings have been correlated to the gold-standard of determining blood flow, i.e. 
spectrometry to calculate the number of microspheres in a sample.42, 77 LDI allows for 
continuous, near real-time monitoring of blood flow to a specified region of tissue (typical 
capillary diameter 10 μm; velocity spectrum measurement between 0.01–1.0 mm/s). 
Measures are limited to the tissue surface (1–1.5 mm depth) unless modified for high 
resolution in which case the tissue sample depth may reach 2-3 mm. Each LDI 
measurement point is used to generate a two-dimensional (2D), color-coded map 
directly related to tissue blood flow. LDI provides a relative estimate of microvascular 
perfusion. Its signal cannot generate absolute values since a single calibration factor 
cannot be determined due to the different optical factors of various tissues. The term 
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‗flux‘ is commonly used to describe blood flow measures. Flux is a quantity proportional 
to the average speed of blood cells times the cell concentration (blood volume), and is 
expressed as arbitrary ‗perfusion units‘ (PU).42, 77 Averaging of several neighboring pixels 
permits comparison between subjects since it helps to compensate for tissue 
heterogeneities.80   
Disadvantages of the LDI method may include low image resolutions and 
possibly long scan times during which the subject has to remain still. LDI is not effective 
in monitoring high frequency flow fluctuations since it depends on sequential versus 
simultaneously captured image points, nor is it effective in extremely low flow situations. 
Nonetheless, LDI offers the ability to study regional variations in tissue blood flow with 
measures that are highly reproducible.   
 
1.6.3.2 Assessment of angiogenesis 
 
LDI, histochemical and angiography methods are inadequate to visualize, 
quantify and characterize vascular development.83 Various vascular filling techniques 
and imaging methods have been used to investigate new blood vessel growth and 
microvasculature parameters. Radio-opaque imaging was first reported by Salmon in 
1936 who perfused a lead oxide gelatin mixture into small radicles of the vascular tree in 
human cadavers for imaging.84  
Perfusion methods have an advantage over immunohistological labeling methods 
in that the former can measure anatomical changes in vascular volume irrespective of 
the pathophysiological status of the tissue being examined. The latter assumes the 
tissue being labeled is the same in a pathological condition as in the normal state, which 
may not be a correct assumption.70 Several different contrast mediums have been used 
for perfusion methods to quantitatively describe fine vascular patterns in tissues.70-71, 85-90 
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One study using India-ink compared the longitudinal orientation and total vessel volume 
in normal and injured rabbit MCLs and found increased vascularity with more chaotic 
angular distribution of blood vessel segments in ligament scar tissue compared to 
normal ligament tissue.85 Many perfusion methods allow acceptable 2D visualization of 
microvascular channels in tissues, but smaller superficial vessels can obscure deeper 
vessels making accurate, quantitative information hard to obtain.73  
Recently developed micro-CT based quantitative methods allow 3D imaging for 
microvascular parameter analysis. These methods typically involve a radiopaque 
silicone rubber containing a suspension of lead chromate, e.g. Microfil®, that is perfused 
into the specimen. Samples are then imaged using a micro-CT scanner.91-92 Micro-CT 
evaluation has been used in a variety of investigations including those determining neo-
vascularization.89, 92-93,94,88 One study on tumor blood vessel formation resolved vessels 
filled with Microfil® smaller than 22 µm in diameter.93 In another study, vessels 8 μm in 
diameter were resolved using high-resolution micro-CT.83 Micro-CT methods overcome 
many of the limitations of other imaging methods since it allows 3D imaging and 
provides a means to obtain quantitative information on volumetric parameters and 
architecture of fine blood vessels without tissue disruption.  
Micro-CT methods are based on the assumptions that the lead chromate is 
mixed homogeneously with the silicone rubber and the vasculature is completely filled, 
but not over-distended.65, 70, 89, 95 Precise estimates of vessel diameter may be difficult to 
obtain due to non-uniformity of the vessel contrast;89, 95 however, micro-CT results have 
been correlated with histological methods for vessel volume analysis.92 Micro-CT cannot 
be done in vivo, nor does it give information on the actual tissue; it simply fills the 
structure;96 however, micro-CT imaging allows unbiased comparisons between the 
tissues of interest.  
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1.7 Response of connective tissue to load 
 
1.7.1 Tissue adaptation to load  
 
 Tissues must be able to adequately respond to external mechanical forces in order 
to adapt to changes in load. This adaptive response is accomplished in part through 
cooperation of mechanical and growth factor signaling. Connective tissue sustains 
mechanical stress and requires it for its growth and maintenance. Remarkably, 
connective tissue cells i.e. fibroblasts, are able to distinguish the mode (i.e. tension, 
compression, shear), frequency, magnitude, direction and duration of applied 
mechanical forces and translate this information into specific tissue adaption response.  
For example, a tendon fibroblast exists primarily under tensile force, but if it is subjected 
to compressive forces, it may form fibrocartilage or sesamoid bone in that specific 
location of pressure (e.g. sesamoid bones embedded in the flexor hallucis brevis 
tendon).97  
The effects of tissue immobilization (inadequate load) and remobilization 
(appropriate overload) on the musculoskeletal system have been well documented.57, 98-
103 Appropriate mechanical loading has been shown to enhance effector cell response. 
The ECM functions to transmit physical forces acting on the body while protecting 
embedded cells from adverse effects from excessive mechanical force. For example, 
fibroblasts sense strains (deformations) in the ECM caused by mechanical stresses and 
translate this stimulus into an adaptive response (i.e. increase or decrease in ECM 
production). Conversely, inappropriate load levels (i.e. overuse or disuse) impair growth 
and survival signals.   
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1.7.2 Effects of inadequate load (disuse) 
 
Models of disuse include forced bed rest104-105 and limb immobilization (i.e. 
casting),106-107 space flight,108-109 and spinal cord injury/paralysis110 and animal hindlimb 
unloading;49, 111 however, joint immobilization has been used most commonly as a model 
of disuse in ligaments and tendons.32, 112-113 The effects of immobilization on connective 
tissue include a permanent loss of GAGs and water leading to a loss of critical inter-fiber 
distance, smaller collagen fiber bundles and increased formation of reducible collagen 
cross-links indicative of immature collagen. New collagen fibrils may form cross-links 
between existing collagen fibers. Cross-links can limit mobility between fibers which may 
interfere with restoration of full, pain-free motion.114-115 New collagen displays a 
disorganized arrangement and its breakdown has been shown to exceed synthesis with 
eventual net loss of collagen and eventual structure weakening observed. Increased 
MMP expression in immobilized connective may be related to accelerated collagen 
breakdown.34 Immobilized ligaments show reductions in ultimate load to failure, stiffness 
and energy absorption. The insertional sites of ligaments, tendons and joint capsules 
demonstrate weakening at soft tissue-bone junctions. Decreased connective tissue 
extensibility, limited joint range of motion and contracture may ensue.116 
 
1.7.3 Effects of excessive overload (overuse) 
 
 Excessive tissue loading results in high tissue strains leading to excess forces 
acting on fibroblasts embedded in the tissue. This can cause inflammation, degeneration 
or cell death (i.e. apoptosis) which can disrupt the repair tissue and delay or prevent 
healing. The effect is magnified if the ECM is already damaged or injured.117 Excessive 
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tissue loading over time can lead to fibrosis. Fibrosis is defined as the excessive 
accumulation of collagen, e.g. excess scar formation in wound healing.29  
 
1.7.4 Effects of overload (re-mobilization) 
 
The deleterious effects of immobilization can be reversed to some degree by re-
mobilization of the soft tissue. Connective tissue mobilization facilitates GAG production, 
which maintains inter-fiber distance and lubrication. Mobilization increases gene 
transcription for ECM proteins, helps maintain the balance between collagen synthesis 
and degradation, improves the matrix organization and increases the strength and 
stiffness of the tissue.97, 118-119 Extensibility can be improved over time due to the 
viscoelastic nature of connective tissue. Besides restoring mobility, mobilization 
activates fibroblast and myofibroblast alignment in the direction of stress, and increases 
cellular activity and proliferation, i.e. in fibroblasts, macrophages, mast cells.119-121 
Increases in blood flow, which can result in a subsequent increase in skin temperature, 
may be related to a histamine response from mast cell degranulation. Appropriate tissue 
loading reportedly reduces muscle tone, releases fascial restrictions and adhesions, 
separates fibers and breaks down collagen cross-links.30, 122 Methods to re-mobilize soft 
tissue may include exercise, modalities and manual therapies. 
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Part B: Manual therapy  
 
1.8 Introduction 
 
Manual therapy involves the application of specifically directed forces to the body 
to induce physiological and/or structural tissue changes. Manual therapy may be 
subcategorized into joint mobilization or STM techniques, the former being directed at 
moving joint surfaces to restore joint motion, the latter being directed at manipulating the 
body‘s supple tissue to improve soft tissue mobility.115 STM can be administered 
manually by hand, or with rigid instruments to facilitate the delivery of the massaging 
force, i.e. instrument-assisted soft tissue mobilization (IASTM). Massage is an ancient 
form of STM that encompasses several approaches.123 CFM, also referred to as 
transverse friction or deep friction massage, is a specific type of deep tissue massage. 
Instruments may be used to augment its delivery, i.e. IACFM. 
 
1.9 Massage 
 
1.9.1 Massage overview 
 
Massage is a form of manual therapy. The earliest writings about massage date 
back to 2,000 B.C. in ancient cultures such as in Chinese, Greek and Roman societies. 
Hippocrates advised rubbing as a treatment for stiffness.123-124 Massage is defined as a 
mechanical manipulation of body tissues with rhythmical pressure and stroking intended 
to promote health and well-being.124 There are currently several massage approaches, 
e.g. classic Swedish massage, Rolfing, acupressure, neuromuscular, myofascial 
release, and IASTM.27, 123, 125 Depending on the clinician experience and desired 
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outcome, techniques are selected and frequently used in the conservative management 
of a variety of conditions; from general to targeted treatment purposes, e.g. sports 
preparation, relaxation, low back pain,126 and neck pain127 to name a few.27, 123, 126, 128-129 
Long-term trends show a growing popularity in complementary and alternative medicine 
(CAM) over the past several decades, especially among the younger population (post-
baby boomers).130 There were an estimated 93.1 million visits to manual therapists in the 
US in 2007.131 Proponents claim many benefits of massage related to mobilizing/re-
mobilizing the soft tissue, e.g. increased soft tissue pliability, increased skin and muscle 
blood flow, decreased pain and muscle spasm, and relaxation. Although there is 
preliminary evidence suggesting massage has beneficial effects, the related research 
remains limited both in quantity and quality.123    
 
1.9.2 Evidence supporting the use of massage 
 
One of the challenges in establishing the efficacy of massage therapy is the 
variety of techniques and potential uses. Some studies indicate massage therapy may 
induce both local and systemic changes. Different mechanisms have been suggested for 
the positive effects of massage, e.g. increased parasympathetic activity, reduced 
neuromuscular excitability, enhanced vascular function, but these are not fully 
understood.123, 127-128 The frequent use of CAM in the management of musculoskeletal 
symptoms (i.e. back, neck, shoulder problems), accounts for about 60% of massage 
applications,27 suggesting a degree of clinical efficacy; however, this needs to be 
explored and demonstrated scientifically. To establish its efficacy, research needs to 
focus on more frequently used massage applications and techniques. One of the 
massage therapy approaches most often employed for the management of 
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musculoskeletal symptoms is deep tissue massage, credited for approximately 65% of 
all massage visits.27  
 
1.10 Cross fiber massage 
 
1.10.1 Cross fiber massage overview 
 
CFM is a specific type of deep tissue massage used by clinicians to treat 
musculoskeletal impairments. In modern times, Dr James Cyriax is credited with the 
technique;132 although, it was first described by Hippocrates.132-133 It is predominantly 
used with injury, overuse or degenerative conditions in muscles, tendons and 
ligaments.134-138 The technique involves moving the skin and subcutaneous tissues over 
deeper tissue lesions so as to exert localized, controlled mechanical forces with the 
intent to induce physiological (e.g. hyperemia) and structural tissue changes, reduce 
pain and prevent adhesions. It differs from other massage techniques in that there is 
little motion between the therapist‘s contact and the patient‘s skin to prevent bruising 
while mobilizing deeper tissues. The direction of the CFM manipulating forces is usually 
applied perpendicular to the underlying collagen substructure. Therefore, it is well suited 
for connective tissues with parallel fiber arrangements, i.e. ligaments and tendons. Since 
reparative cells (fibroblasts) are mechanosensitive and respond to external loading of 
their environment, it is theorized that CFM stimulates fibroblasts collagen production and 
scar formation, without stretching or tearing the healing fibers.139-140,141-142 Rigid devices 
are often used to augment CFM implementation (i.e. IACFM). 
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1.10.2 Instrument-assisted cross fiber massage 
 
Instruments have been used to augment the manual delivery of massage 
techniques for millennia.143 Hand held rigid instruments used to augment manual 
therapies may be comprised of common devices (i.e. stones, pencils, soup spoons), or 
specially designed tools (i.e. contoured stainless steel instruments). IACFM is a type of 
CFM that employs hand-held instruments made out of solid materials to administer 
localized mechanical forces to soft tissue structures (Figure 1.2). IACFM is currently 
used by several clinics and athletic organizations.125 IAFCM may provide benefits over 
the traditional means of manually applying the CFM force by hand only, in that IACFM 
simultaneously offers mechanical leverage to the clinician along with precise application 
and depth of penetration of the treatment force during soft tissue examination and 
treatment.144 Other purported advantages include enhanced detection and treatment of 
soft tissue dysfunctions, especially when using instruments with uniquely designed 
treatment edges, contoured shapes and materials (i.e. lucite, acrylic, ceramics or 
stainless steel).144-145 Secondary benefits of IACFM are improved therapist joint comfort 
and reduced fatigue; perhaps due to improved wrist and hand ergonomics.146  
 
1.10.3 Evidence supporting the use of cross fiber massage approaches 
 
CFM has been used with mixed results for a multitude of conditions, including 
tendonitis, ligament sprains, and bursitis. CFM has been shown to immediately improve 
muscle function as indicated by an increase in force production;147-148 however, its 
longer-term effects on soft tissue dysfunction have not been firmly established. For 
example, CFM has not shown consistent benefit in the management of pain or functional 
deficits in infrapatellar tendinopathy149 or iliotibial band friction syndrome.150 A recent 
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Figure 1.2. Cross fiber massage approaches. Cross fiber massage is 
depicted being delivered to the knee MCL in a human subject 
manually A) by hand and B) augmented by use of a rigid device 
made of stainless steel, i.e. instrument-assisted cross fiber massage 
(IACFM). Arrows indicate the direction of movement forces 
perpendicular to ligament fiber alignment. 
A 
 
B 
A 
B 
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study demonstrated decreased motor neuron pool excitability in forearm flexor muscles 
treated with CFM.151 It has been suggested that CFM introduces a controlled amount of 
microtrauma into the tissue that triggers the healing cascade; however, this has not been 
substantiated in ligament.144-145 Conclusions regarding the effectiveness of CFM is 
limited by the small sample sizes of the previous randomized controlled trials.123, 150, 152 
Clinical pilot studies using IACFM have demonstrated positive outcomes for 
diagnoses such as carpal tunnel syndrome,153 chronic ankle pain,154 plantar fasciitis, 
achilles and supraspinatus tendinosis.155 For patellar tendinopathy, IACFM had better 
efficacy than standard CFM using the fingers.156 Initial animal model studies found 
IACFM applied to chemically induced rat Achilles tendon injuries increased fibroblast 
proliferation and activation, especially at higher therapeutic pressures, which may be 
related to improved healing.157-158  
Preliminary evidence suggests CFM approaches may benefit tissue healing and 
repair, but its efficacy needs to be further established. The ultimate outcome of any 
healing process in load-bearing tissue, such as a ligament, is the restoration of 
mechanical properties. To assess tissue strength, an animal model is necessary since it 
requires destructive mechanical testing; as does the assessment of microvascular 
structural parameters associated with healing. In order to help answer the important 
clinical question regarding the benefits of CFM, a precise form of CFM, IACFM, will be 
used to investigate its tissue level effects in healing ligaments using an established 
rodent model.  
 
1.11 Summary and general aims 
 
Ligament injuries are common clinical disorders resulting in functional limitations 
and disability. A number of interventions exist for this condition; however, a limited 
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number have been shown to accelerate or augment ligament healing. STM techniques, 
such as CFM, offer conservative, manual therapy alternatives to invasive procedures 
and pharmaceuticals in promoting ligament healing. The purpose of this dissertation is to 
investigate the effects of a discrete CFM approach, specifically IACFM, on ligament 
healing. An established rodent model for knee ligament injury will be used in all studies. 
A basic understanding of the tissue-level effects of this form of manual therapy is 
needed to support clinical decision-making leading to optimal therapeutic outcomes. 
 
The general aims of this dissertation are to investigate the: 
1. Short and long-term effects of IACFM on biomechanical and histological 
properties during knee ligament healing. 
2. Effects of IACFM on regional blood flow and angiogenesis during early knee 
ligament healing. 
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CHAPTER TWO 
The Short and Long Term Effects of Instrument-Assisted Cross Fiber Massage on 
Biomechanical and Histological Properties in Healing Ligaments 
 
2.1 Introduction 
 
CFM exerts localized mechanical forces through the skin and subcutaneous 
tissues to deeper connective tissues. As the reparative cells (fibroblasts) responsible for 
producing collagen and forming a scar following ligament injury are 
mechanosensitive,141-142 it is possible that IACFM, a type of CFM described in Chapter 
One, facilitates matrix production and the restoration of tissue-level mechanical 
properties. 
Based on preliminary evidence demonstrating the potential efficacy of IACFM 
and its mechanical mechanism of action, the aim of this set of studies were to examine 
the short- and long-term effects of IACFM on tissue-level healing of knee MCL injuries in 
an established animal model. It was hypothesized that IACFM would accelerate early 
and augment long-term ligament healing. The primary variables of interest were ligament 
mechanical properties since the ultimate outcome of any healing process in a load-
bearing tissue, such as ligament, is the restoration of its mechanical properties. The 
secondary variable of interest was ligament morphology as this may help to explain 
differences in tissue mechanical properties. 
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2.2 Methods 
 
2.2.1 Animals  
 
Fifty-eight six-month-old, virgin, female, Sprague-Dawley rats (280-300 grams) 
were purchased from Harlan Sprague-Dawley, Inc. (Indianapolis, IN) and acclimated for 
a minimum of seven days prior to experimentation. Animals had ad libitum access to 
standard rat chow and water at all times, and were housed two per standard sized cage 
(16‖L x 7.75‖W x 8‖H). All procedures were approved a priori by an Institutional Animal 
Care and Use Committee.  
 
2.2.2 Ligament injury 
 
 Fifty-one animals underwent surgery on entry to the study to create bilateral knee 
MCL injuries (‗injured‘ animals) as previously described.22 The remaining seven animals 
served as age-matched, ligament-intact cage controls and were not operated on 
(‗control‘ animals). Following a pre-operative subcutaneous dose of buprenorphine 
hydrochloride analgesia (0.05 mg/kg; Buprenex®—Reckitt & Colman Pharmaceuticals 
Ltd., Richmond, VA), surgical anesthesia was achieved using a mixture of ketamine (60-
80 mg/kg; Ketaset®—Fort Dodge Animal Health, Fort Dodge, IA) and xylazine (7.5 
mg/kg; Sedazine®—Fort Dodge Animal Health, Fort Dodge, IA) introduced 
intraperitoneally. Using a sterile technique, a 5 mm longitudinal incision was made over 
one knee medial joint line, and the MCL sharply transected at the joint line using a size 
11 scalpel blade. This resulted in complete disruption of the MCL at its mid-substance, 
transverse to the underlying collagen fiber alignment. No ligament material was 
removed, and the ligament ends were juxtaposed but not sutured prior to closing of the 
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skin incision with a single subcuticular absorbable suture. The procedure was repeated 
on the contralateral side to create bilateral injuries. All animals demonstrated normal, 
symmetrical hindlimb use upon recovery from surgery and were allowed normal cage 
activity (without access to exercise wheels) for the duration of the study. 
 
2.2.3 IACFM intervention 
 
 IACFM was introduced using a rigid tool fabricated from stainless steel (GT6—
Graston Technique®, TherapyCare Resources, Indianapolis, IN). The ‗GT6‘ instrument 
was used since it is designed to apply force through its tip to small structures, such as 
finger collateral ligaments in humans (i.e. rat knee-sized ligaments) (Figure 2.1). IACFM 
was initiated one week post-operatively (post-injury) to allow the initial inflammatory 
response/phase of ligament healing to complete based on healing and repair timelines. 
Delaying the initial introduction of IACFM is consistent with its clinical use following an 
acute injury.155 IACFM was administered with the animals under isoflurane anesthesia 
(3% at 1.5 l/min for initial knock-down in a plastic container, and 1.5% at 1.5 l/min via a 
face mask for maintenance of anesthesia). Approximately 250-300 g of instrument 
downward force was applied during treatment. This force was equivalent to that 
previously used in demonstrating IACFM benefits on rat Achilles tendon healing,158 and 
was determined by using the massage instrument on a force plate with kinesthetically 
similar pressure as would be used clinically to treat a comparably sized ligament at an 
equivalent tissue depth (i.e. collateral ligament of a human interphalangeal joint). Thirty-
one injured animals were treated three times per week for three weeks (total treatments 
= 9), while the other 20 injured animals were treated three times per week for 10 weeks 
(total treatments = 30). The number of treatments in the later animals is more than would 
typically be introduced in a clinical setting; however, were implemented to maximize the 
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potential of finding any long-term benefit of IACFM. IAFCM was applied to the left MCL 
in injured animals for one minute per session (IACFM-treated). This treatment duration 
was based on the recommended clinical use of IACFM for the treatment of isolated 
tissue lesions159 and evidence from previous preclinical studies demonstrating the 
efficacy of short duration IACFM interventions.157-158 The contralateral, injured MCL in 
these animals served as an internal control and did not receive IACFM (non-treated). 
The seven control animals were not treated with IACFM. 
 
2.2.4 Assessment time points and specimen preparation 
 
 Animals were euthanized post-injury at either four (all animals treated for nine 
sessions [N=31] and two control animals) or 12 (all animals treated for 30 sessions 
[N=20] and five control animals) weeks. Animals euthanized at four weeks had both 
hindlimbs harvested and prepared for mechanical testing (N=18 injured animals), 
scanning electron microscopy (SEM) (N=11 injured and N=2 control animals) or 
histological assessment (N=2 injured animals). Animals euthanized at 12 weeks had 
both hindlimbs removed and prepared for mechanical testing (N=17 injured; N=4 control 
animals) or histological assessment (N=3 injured; N=1 control animals). 
 
2.2.5 Mechanical testing  
 
 Ligament mechanical properties were assessed as previously described.160-161 
Hindlimbs destined for mechanical testing were initially stored at –80°C with the knee 
tissues intact. Postmortem storage of ligaments by freezing does not influence their 
mechanical properties.162 On the day of mechanical testing, the hindlimbs were allowed  
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Figure 2.1.  IACFM intervention. A) The rigid Graston Technique® GT6 tool fabricated 
from stainless steel has a tapered tip (*) which permits treatment of small structures. 
IACFM of a: B) human finger, and; C) similarly-sized rodent knee joint medial collateral 
ligament using the GT6 tool. Arrows indicate the direction of movement/force application 
perpendicular to the collagen substructure of the ligament. 
38 
 
 to thaw to room temperature in phosphate-buffered saline (PBS). Femoral-MCL-tibial 
(FMT) complexes were prepared, by dissecting clear extraneous tissue (including the 
joint capsule and adherent medial meniscus) while keeping the MCL and its insertion 
sites hydrated with PBS. The femoral and tibial insertions of the MCL were left intact, 
and the proximal tibia growth plate was removed to permit more space within the knee 
joint during testing. MCL thickness and width were measured optically at the knee joint 
line, and MCL area estimated using an elliptical geometry.49 Each FMT complex was 
placed in a customized testing jig with the knee joint positioned in 70° flexion for MCL 
testing. This position appears to load all ligament fibers simultaneously.49 The femoral 
and tibial portions were embedded in Wood‘s low melting-point metal (Bismuth alloy 
LMA-117—Small Parts, Inc., Miami Lakes, FL) for fixation. The jig was coupled to an 
electromagnetic material testing device (TestBench 200 N ELF LM-1—EnduraTEC 
Systems Group, Bose Corp., Minnetonka, MN) equipped with a 50 N load cell (Figure 
2.2). This system possesses a force and displacement resolution of 0.01 N and 0.001 
mm, respectively. A preload of 0.05 N was applied and the ligaments were 
preconditioned by cyclically loading at 1 Hz for 10 cycles to 1% strain to reduce the 
effect of deep freezing on low-load mechanical properties by normalizing area of 
hysteresis.162 The ligaments were unloaded and allowed to recover for 1.5 minutes while 
being kept moist with PBS. Following tissue recovery, ligaments were again preloaded 
(0.05 N) and pulled to tensile failure in displacement control at a rate of 0.8 mm/s 
(~10%/s). Force and displacement data were collected at 100 Hz, and the mechanical 
properties of ultimate force (N), stiffness (N/mm) and energy to failure (mJ) obtained 
from the force-displacement curves. 
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Figure 2.2.  Tensile mechanical testing of rat knee medial collateral ligaments. 
Representative image of the setup for testing. Femur-MCL-tibia complexes were placed 
in fixtures that supported (‗cupped‘) the distal femur and proximal tibia to prevent bone 
slippage, and fixed in place using Wood‘s low melting-point metal. The knee joint was 
positioned in 70° of flexion for testing.  
 
 
2.2.6 Scanning electron microscopy 
 
 Immediately after harvest, specimens for SEM were placed in a custom limb frame 
that held the knee positioned in 70° flexion. The MCL was exposed and drip fixed for one 
hour with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) (Electron 
Microscopy Services, Hatfield, PA). After drip fixation, the MCLs were removed using a 
micro-surgical scalpel with the femoral insertion marked by an angled cut. Any adherent 
tissue was removed under a dissecting microscope. Ligaments were then rinsed twice in 
buffered solution, and dehydrated by immersing for 15 minutes each in fresh solutions of 
70%, 95% and 100% ethyl alcohol. They were subsequently immersed in liquid nitrogen, 
placed on pre-cooled microscope slides and fractured under a dissecting microscope in 
the sagittal plane from the femoral to tibial end using one-half of a pre-cooled double-
edged stainless steel razor blade (Electron Microscopy Sciences, Hatfield, PA). The 
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ligament samples were then critical point dried (Samdri model 780A—Tousimis 
Research Corp., Rockville, MA), mounted on 10 mm SEM specimen mount blocks using 
non-conductive adhesive tabs (Ted Pella, Inc., Redding, CA), and surrounded by 
colloidal silver paste (Electron Microscopy Sciences, Hatfield, PA). After drying overnight 
in a vacuum dessicator with dissecant, the samples were sputter coated with gold-
palladium (Polaron, Energy Beam Sciences, East Gramby, CT) for 1.75 minutes, and 
stored in a vacuum dessicator with desiccant until imaged. The samples were imaged on 
a scanning electron microscope (JSM-6390LV—JEOL Ltd., Peabody, MA) using a 5kV 
accelerating voltage and working distance of 11 mm. The ligaments were aligned at low 
magnification (approximately X25) by orienting the femoral end of the ligament to the top 
of the screen, and the residual and scar regions were identified. The morphology of 
collagen fibrils and fibers for each ligament in the residual and scar tissue regions were 
examined at magnifications of X250 to X11000, and digitally imaged.  
 
2.2.7 Histology 
 
 Ligaments for histology were fixed under tension in 4% paraformaldehyde at 4°C 
for 48 hours. They were subsequently dehydrated in graded alcohols, washed with two 
changes of xylene, and infiltrated and embedded in paraffin using a Shandon automatic 
tissue processor (Thermo Electron Corp, Waltham,. MA). Sagittal plane thin (4 µm) 
sections were cut using a rotary microtome (Reichert-Jung Model 2050; Reichert-Jung, 
Heidelberg, Germany), mounted onto microscope slides, and stained with Harris‘ 
hematoxylin and eosin (H&E) on a linear stainer (Shandon Linistain GLX—Thermo 
Electron Corp, Waltham, MA). Three sections per specimen were qualitatively assessed 
for collagen fiber alignment and cellularity under light microscopy using a Nikon 
Optiophot 2 microscope (Nikon, Inc., Garden City, NY). 
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2.2.8 Statistical analyses 
 
 Statistical analyses were performed using the Statistical Package for Social 
Sciences (SPSS 16.0—SPSS Inc., Chicago, IL). All comparisons were two-tailed with a 
level of significance set at 0.05. Unpaired t-tests were performed to assess time (four vs. 
12 weeks post-injury) and group (injured vs. control animals) effects on body mass. The 
Kolmogorov–Smirnov test normality test was used to determine a normal distribution of 
the data. IACFM effects were principally determined using paired t-tests to compare 
IACFM- and contralateral non-treated MCLs. Paired t-test results were confirmed by 
calculating mean percent differences between IACFM- and non-treated MCLs ([IACFM-
treated – non-treated] / non-treated x 100), which were analyzed using single sample t-
tests with a population mean of 0%. 
 
2.3 Results 
 
2.3.1 Animal characteristics 
 
 There were no operative or post-operative complications. Animals assessed at 12 
weeks post-injury were significantly heavier than those assessed at four weeks (291.4 ± 
13.2 g vs. 313.5 ± 22.6 g; p<0.05). There were no differences in weight between injured 
and control animals (p=0.76).  
 
2.3.2 Ligament macroscopic morphology 
 
 All surgically-induced ligament defects were bridged with scar tissue at the time of 
harvest. At four weeks post-injury, the injured region was clearly distinguishable from the 
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uninjured ligament tissue by the presence of a thickened, somewhat translucent, pinkish 
scar. In comparison, ligaments at 12 weeks post-injury had difficult to see whitish scars 
that were relatively indistinguishable from the uninjured tissue, and the thickness of the 
scar region was continuous with that of the uninjured portions of the ligament. There 
were no grossly observable differences between IACFM- and non-treated ligaments at 
either four or 12 weeks post-injury; however, non-treated ligaments often had more 
adhesions and granular tissue, and were more difficult to harvest than IACFM-treated 
ligaments. Cross-sectional area of IACFM- and non-treated ligaments did not differ 
significantly at either four (5.46 ± 1.01 mm2 vs. 5.16 ± 1.55 mm2; p=.45) or 12 (3.80 ± 
1.02 mm2 vs. 4.09 ± 0.79 mm2; p=0.29) weeks post-injury. 
 
2.3.3 Ligament mechanical properties 
 
 At four weeks post-injury, IACFM-treated ligaments could resist 6.4 N (95% 
confidence interval [CI], 1.6 N to 11.2 N; p=0.01) greater force than contralateral non-
treated ligaments (Figure 2.3A). This was reflected by IACFM-treated ligaments having 
43.1% (95% CI, 8.2% to 78.0%; p=0.02) greater mean difference in tensile strength than 
non-treated ligaments. Similarly, IACFM-treated ligaments had 4.9 N/mm (2.4 N/mm to 
7.4 N/mm; p=0.001) (Figure 2.3B) and 5.8 mJ (95% CI, 0.7 mJ to 10.9 mJ; p<.05) 
(Figure 2.3C) greater stiffness and energy to failure at four weeks post-injury than non-
treated ligaments, respectively. This was reflected by IACFM-treated ligaments being 
39.7% (95% CI, 15.9% to 63.5%; p<.01) stiffer and being able to absorb 57.1% (95% CI, 
3.4% to 110.9%; p=0.04) greater energy before failure than non-treated ligaments. 
 At 12 weeks post-injury, IACFM-treated ligaments had 2.6 N/mm (95% CI, 0.2 
N/mm to 5.0 N/mm; p<.05) greater stiffness than non-treated ligaments, resulting in the 
former being 15.4% (95% CI, 0.1%-30.7%; p<.05) stiffer (Figure 2.4B). However, there 
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were no differences at 12 weeks post-injury between IACFM- and non-treated ligaments 
in ultimate force (1.1 N; 95% CI, -2.6 N to 4.7 N; p=0.54) (Figure 2.4A) or energy to 
failure (-0.6 mJ; 95% CI, -6.7 mJ to 5.5 mJ; p=0.84) (Figure 2.4C). Mechanical properties 
of ligaments in injured animals at both four and 12 weeks post-injury remained inferior to 
intact, non-injured ligaments from control animals (p<0.05). 
 
 
Figure 2.3.  Effect of nine sessions (1 min/session) of IACFM on ligament mechanical 
properties assessed at four weeks following injury. IACFM-treated ligaments had 
greater: (A) ultimate force; (B) stiffness, and; (C) energy to ultimate force than 
contralateral, non-treated ligaments. *indicates p<0.05 and **indicates p<0.01, as 
determined via single sample t-tests on the mean percent differences with a population 
mean of 0%. Error bars indicate standard deviation. 
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Figure 2.4.  Effect of 30 sessions (1 min/session) of IACFM on ligament mechanical 
properties assessed at 12 weeks following injury. IACFM-treated ligaments had: (A) 
equivalent ultimate force; (B) enhanced stiffness, and; (C) equivalent energy to failure 
than contralateral, non-treated ligaments. *indicates p<0.05, as determined via single 
sample t-test on the mean percent difference with a population mean of 0%. Error bars 
indicate standard deviation. 
 
2.3.4 Ligament microscopic morphology 
 
 Light microscopy of non-injured ligaments from control animals revealed a uniform 
appearance of tightly-packed, well-aligned collagen fibrils with interspersed fibroblasts 
aligned parallel to the fibrils (Figure 2.5A). In contrast, ligaments from injured animals 
appeared to have scar morphology with ECM disorganization and hypercellularity, 
particularly at four weeks post-injury (Figure 2.5B-E). The scar region of IACFM-treated 
ligaments at four weeks post-injury also appeared to have greater cellularity with 
collagen fiber bundles appearing to be orientated more along the longitudinal axis of the 
ligament than observed in contralateral non-treated ligaments (Figure 2.5B, C). At 12 
weeks post-injury, there were limited histological differences between IACFM- and non-
treated ligaments (Figure 2.5D, E). 
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Figure 2.5.  Representative histological sections from: A) non-injured MCL in a cage-
control animal; B) scar region in a non-treated MCL at four weeks following injury; C) 
scar region in an IACFM-treated MCL at four weeks following injury; D) scar region in a 
non-treated MCL at 12 weeks following injury, and; E) scar region in an IACFM-treated 
MCL at 12 weeks following injury. Black arrows indicate fibroblasts aligned parallel to the 
collagen fibrils in a non-injured ligament. White arrows indicate scar region in injured 
ligaments.  
 
 
Ligaments from injured, but not control, animals had granular tissue at low 
magnification (X25) on SEM and IACFM-treated ligaments appeared to have less 
surrounding granular tissue compared to non-treated ligaments, confirming the 
macroscopic observations (Figure 2.6). At higher SEM magnifications (X250-X6500), the 
scar region of IACFM-treated ligaments appeared to have improved collagen fiber 
bundle formation and orientation within the scar region than non-treated ligaments, 
supporting the light microscopy observations (Figure 2.7).  
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Figure 2.6. Representative scanning electron microscopy images at low magnification 
taken from a: A) intact ligament in a control animal; B) non-treated ligament at four 
weeks following injury, and; C) IACFM-treated ligament at four weeks following injury. 
Images were taken at low [X25] magnification. Note the close appearance of the IACFM-
treated ligament (C) to the non-injured ligament from a control animal (A). Also, note the 
large amount of surrounding granulation tissue in the non-treated, but injured ligament 
(B) relative to the other two ligaments. 
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Figure 2.7.  Representative scanning electron microscopy images taken from the scar 
region of a: A & B) non-treated, and; C & D) IACFM-treated ligament at four weeks 
following injury. Images were taken at: A & C) medium [X250], and; B & D) high [X6500] 
magnification. Note the improved collagen fiber bundle formation and orientation within 
the scar region of the IACFM-treated ligament (C, D) relative to that of the non-treated 
ligament (A, B). 
 
2.4 Discussion 
 
This set of studies investigated the potential utility of manual therapy in the form 
of IACFM on ligament healing. Results indicate that IACFM-treated ligaments were 43% 
stronger, 40% stiffer and able to absorb 57% more energy than contralateral, non-
treated, injured ligaments at four weeks following injury. These mechanical differences 
may have resulted from favorable effects of IACFM on the organization of the underlying 
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collagen substructure, as suggested by preliminary light microscopy and SEM analyses. 
The latter needs to be confirmed by way of more in-depth quantitative analyses in future 
studies. In contrast, there was minimal effect of IACFM on ligament healing when 
assessed at 12 weeks following injury, with the only difference between IACFM- and 
non-treated ligaments being 15% greater stiffness in the former. Overall, the findings 
suggest that IACFM accelerates early tissue-level healing following ligament injury, but 
does little in terms of augmenting later healing. 
The findings of the current study are interesting in that a relatively simple and 
practical manual therapy technique was found to enhance early recovery of ligament 
biomechanical properties following acute injury. How IACFM facilitates the restoration of 
ligament tensile mechanical properties following injury was not investigated in detail as 
the primary purpose was to provide proof-of-concept evidence for the utility of IACFM. 
However, preliminary light microscope and SEM assessments suggest that IACFM may  
enhance restoration of ligament biomechanical healing by optimizing the organization of 
the collagen substructure. The alignment and organization of newly formed collagen 
fibers in the direction of tensile loads during healing influences ligament mechanical 
properties.49, 163 The qualitatively improved collagen fiber organization observed within 
the scar region of IACFM-treated ligaments is a possible explanation for why IACFM-
treated ligaments had enhanced tensile mechanical properties.  
 Preliminary data indicate that IACFM accelerates the initial return of mechanical 
properties following acute ligament injury and improves ligament stiffness. These 
findings support a theoretically sound argument for the use of IACFM after acute 
capsular/extra-capsular ligament injury; however, careful interpretation of this controlled 
laboratory study is warranted until its findings are confirmed by clinical studies. 
Furthermore, these findings do not answer the important question of how healing is 
enhanced. Recent studies have found increased blood flow and angiogenesis positively 
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affects the return of mechanical properties in injured ligament.164-165 Since a purported 
benefit of massage techniques is increased tissue perfusion, potential mechanisms 
underlying the beneficial effects of IACFM demonstrated thus far may involve 
improvements in the vascular properties of injured knee ligaments.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 
 
CHAPTER THREE 
The Effects of Instrument-Assisted Cross Fiber Massage on                                                                
Regional Blood Flow and Angiogenesis 
 
3.1 Introduction 
 
Initial findings in this research program demonstrated IACFM accelerated the 
return of tissue-level mechanical properties in healing knee MCLs when assessed at four 
weeks post-injury in an established animal model. While these findings support previous 
studies suggesting the efficacy of IACFM, it did not address the important question of 
how IACFM enhances ligament healing. Subsequent studies were designed to 
investigate mechanisms that could contribute to the beneficial effects of IACFM on 
ligament healing.  
Based on the fact that each phase of ligament healing requires adequate blood 
supply for the transport of cells and metabolites, it seemed logical that IACFM-induced 
alterations in tissue perfusion could have influenced the ligament healing process.41, 63, 73 
Therefore, the aim of this set of studies was to investigate the effect of IACFM on 
regional vascular properties during early knee MCL healing in rodents. The specific 
variables of interest were tissue perfusion and microvascular morphology. It was 
hypothesized that IACFM-treated injured knees would demonstrate a) increased regional 
tissue blood flow, either at some or all assessment points, and b) altered microvascular 
morphology parameters suggesting angiogenesis during early ligament healing. 
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3.2 Methodology 
 
3.2.1 Animals 
 
Thirty adult, virgin, female, Sprague-Dawley rats (6 months; 280-300 g) were 
purchased from Harlan Spraque-Dawley, Inc. (Indianapolis, IN) and acclimated for a 
minimum of 7 days prior to experimentation. Animals were housed in standardized 
conditions with ad libitum access to standard rat chow and water at all times. All 
procedures were approved a priori by the Institutional Animal Care and Use Committee 
of Indiana University. 
 
3.2.2 Ligament injury 
 
All animals underwent surgery to create bilateral knee MCL injuries. The surgical 
procedure was the same as previously described in Chapter Two (Section 2.2.2).  
 
3.2.3 IACFM intervention 
 
IACFM was initiated one week following injury (post-acute) to allow completion of 
the initial inflammatory response/phase. The IACFM intervention was administered for 
one minute, three times per week for three weeks (total=9 treatment sessions) as 
previously described in Chapter Two (Section 2.2.3).  
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3.2.4 Assessment of superficial regional tissue perfusion 
 
Regional superficial tissue perfusion was assessed in vivo in one set of animals 
(n=11) using noninvasive laser Doppler imaging (LDI). A desktop scanning laser-Doppler 
perfusion imager (MoorLDI2-IR™; Moor Instruments, Wilmington, DE) modified by the 
manufacturer for high resolution and maximum depth of penetration (2-3 mm) was used 
which possessed a laser diode source that produced near-infrared energy with a 
wavelength of 785 nm and nominal power of 2.25 mW. A low-frequency cut-off (250 Hz) 
was used to eliminate movement artifacts, while a high-frequency cut-off (15 kHz) was 
used to improve the signal-to-noise ratio.  
LDI was performed in a standardized environment (22°C) with animals under 
inhalation anesthesia. The hindlimbs were shaved, and the animals were placed in 
dorsal recumbency on a warming pad (37°C) with both hindlimbs abducted to permit 
imaging of the medial knee joint region. Both hindlimbs were positioned within a single 
field of view to allow simultaneous scanning of the IACFM- and non-treated hindlimbs. 
The imager and animal were subsequently enclosed in an opaque screen to eliminate 
artifactual light during scanning. After animals were positioned they were left undisturbed 
for 10 minutes before scanning to reduce handing and environmental influences on 
tissue perfusion measures.77 
Triplicate scans of each animal were performed without interim repositioning at 
the following time points: the day prior to surgically-induced MCL injury (pre-injury), 
immediately prior to each IACFM intervention (pre-IACFM), and at 0, 5, 10, 15 and 20 
minutes, and 24 hours following IACFM intervention (post-IACFM). A final assessment 
was performed 1 week following the final IACFM intervention (4 week post-injury). As the 
IACFM- and non-treated hindlimbs were simultaneously scanned within each animal, the 
influences of subtle changes in ambient temperature and light and physiological status of 
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the animals were controlled. An identical region of interest (ROI) was selected over the 
medial knee region on the acquired 2D images, and mean flux values were obtained for 
both the IACFM- and non-treated hindlimbs. These flux values were averaged for the 
triplicate scans performed on each hindlimb at each assessment time point. The MCLs 
from these animals were harvested at 4 weeks post-surgery and used for assessment of  
morphological properties under SEM.  
 
3.2.5 Assessment of regional microvasculature morphology 
 
Microvasculature morphology was assessed in a second set of animals (n=19) by 
micro-CT imaging of tissues perfused with a contrast agent, as previously described.91-92 
Animals were anesthetized at 4 weeks post-surgery (1 week following the final IACFM 
intervention) with an intraperitoneal injection of ketamine (60-80 mg/kg; Fort Dodge 
Animal Health, Fort Dodge, IA) and xylazine (7.5 mg/kg; Fort Dodge Animal Health, Fort 
Dodge, IA). They were placed on a warming pad (37°C) in dorsal recumbency with their 
appendages splayed and fixed. The thoracic cavity was opened and the inferior vena 
cava located and severed to exsanguinate the animals. A 16-G cannula needle 
connected to a perfusion pump (Minipuls 2 Peristaltic Pump; Gilson Inc., Middleton, WI) 
was inserted through the left ventricle of the heart and into the ascending aortic. The 
vasculature was flushed with 0.9% normal saline containing heparin sodium (100U/ml) 
and sodium nitrite before being pressure fixed with 4% phosphate-buffered formalin. 
Formalin was flushed using heparinized saline and the vasculature perfused with a 
radiopaque silicone rubber containing lead chromate (Microfil MV-122, Flow Tech, Inc., 
Carver, MA). Following storage at 4°C overnight to allow contrast agent polymerization, 
the hindlimbs were removed and soaked in 10% neutral buffered formalin for 4 days to 
ensure complete tissue fixation.  
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Immediately prior to micro-CT imaging, the MCLs and their adjacent connective 
tissues were harvested and dissected to a standard sample size (length=1.5 cm, 
width=0.5 cm). Surrounding connective tissue was included in analyses as the MCL 
proper has limited vascularity and receives its blood supply from vessels in its 
epiligament and the adjacent peri-articular tissues (related discussion in Chapter One; 
Section 1.6.1). This approach maximized the number of vessels assessed, with the 
tissues containing these vessels also being injured during surgery and subsequently 
treated during IACFM intervention. Samples were custom mounted and positioned 
vertically on the computer-controlled rotation stage of a bench top micro-CT system 
(SkyScan 1172 high-resolution micro-CT; SkyScan, Kontich, Belgium) (Figure 3.1A) and 
scanned 359° around the vertical axis in rotation steps of 0.4° using an x-ray source 
operating at 50kV. The isotropic voxel size was 5.9 µm. Serial tomograms were 
reconstructed (Figure 3.1B) and images were binarized to segment the radiopaque 
microvasculature network from its surrounding connective tissue (threshold of 85 for 
blood vessels and 15 for connective tissue on a 0-255 scale).This was performed for the 
whole tissue and femoral, middle and tibial subregional thirds. Microvascular 
morphometric parameters for the volume of interest (VOI) included: vessel volume 
normalized to tissue volume (VV/TV; %), vessel thickness (V.Th; µm) (a.k.a. vessel 
diameter), vessel separation (V.Sp; µm), vessel number (V.N; /µm), and frequency 
distribution of V.Th.  
 
3.2.6 Statistical analyses 
 
 IACFM effects on regional blood flow at each time point were principally 
determined using paired t-tests to compare in IACFM- and contralateral non-treated 
hindlimbs. Flux values in IACFM-treated hindlimbs were expressed relative to those 
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measured in non-treated hindlimbs (IACFM treated/non-treated) to provide a perfusion 
ratio for each individual animal. Intervention effects were further assessed at each 
timepoint by calculating mean perfusion ratios and their 95% CI. The 95% CIs not 
crossing 1 were considered statistically significant, as determined by single sample t-
tests on the mean perfusion ratios with a population mean of 1. Intervention effects on 
regional microvasculature morphology were assessed using paired t-tests. All 
comparisons were with a level of significance set at 0.05.   
 
3.3 Results 
 
3.3.1 Regional tissue perfusion 
 
A representative laser Doppler image of the left and right hindlimbs 1 week after 
the final IACFM treatment is depicted in Figure 3.2. There were no side-to-side 
differences in regional tissue blood flow in animals prior to surgically-induced MCL injury, 
or immediately prior to the initial IACFM intervention (all p>0.05). There was no 
immediate effect of IACFM on tissue perfusion, with IACFM- and non-treated hindlimbs 
having equivalent perfusion immediately, and 5, 10, 15 and 20 minutes following the 
initial IACFM treatment session (all p>0.05) (Figure 3.3A). However, when assessed 24 
hours following the 4th and 9th (last) treatment sessions (15 and 26 days post-injury, 
respectively) IACFM-treated hindlimbs had significantly greater tissue perfusion than 
contralateral non-treated hindlimbs (all p<0.05) (Figures 3.3B). In addition to having 
increased perfusion at these times, IACFM-treated hindlimbs also had significantly 
greater perfusion when assessed 1 week following the final treatment session (p<0.05) 
(Figure 3.3B).  
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Figure 3.1. Methods for 
assessment of regional 
microvasculature morphology. 
A) Representative radiographic 
image of a tissue sample 
mounted and positioned in the 
micro-CT scanner. Ligament 
samples and their surrounding 
connective tissue were 
wrapped in clear plastic to 
prevent drying during the 
scanning procedure. Care was 
taken not to distort the tissue. 
The wrapped sample was then 
placed in a small clear plastic 
tube and secured with cotton 
packing and parafilm at the end 
of the tube out of view of the 
sample region, and mounted on 
the micro-CT stage. An angled 
cut was used to identify the 
femoral end of each sample 
(top of image).    
 
B)  Representative image of a 
reconstructed serial tomogram.  
 
In both A) and B), single white 
asterisks indicate the plastic 
tube; white arrows point to the 
plastic wrap and black arrows 
denote blood vessels filled with 
radiopaque contrast agent. The 
double white asterisks in B) 
marks the empty space within 
the tube. The black asterisk in 
B) portrays the connective 
tissue. The ligament is not 
distinguishable from its 
surrounding connective tissue 
in either A) and B) due to 
similar radio-densities.
 
 
A 
B 
* * 
* 
* 
** 
** 
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Figure 3.2. Representative laser Doppler image of the left and 
right injured hindlimbs 1 week after the final IACFM treatment. 
Tissue perfusion (flux) was increased in the IACFM-treated 
hindlimb (*) as indicated by the greater redness. 
* 
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Figure 3.3. Effect of IACFM on regional tissue perfusion following knee MCL injury. 
A) IACFM had no immediate effect on tissue perfusion ratios, with ratios immediately 
prior (PRE) and after (0) the first IACFM treatment, at 5, 10, 15 and 20 minutes post-
treatment, and at 24 hours post-treatment not differing significantly from 1 (i.e. 
perfusion in IACFM-treated = perfusion in non-treated). B) IACFM significantly 
increased tissue perfusion over time. Data during ‗IACFM intervention‘ indicate 
perfusion ratios when assessed 24 hours following an IACFM treatment session. In 
addition to having increased perfusion when assessed at 24 hours post-treatment, 
IACFM treated hindlimbs had significantly greater perfusion when assessed one 
week following the final treatment session. Data represent the perfusion ratios 
(IACFM treated/non treated) between IACFM treated and non-treated hindlimbs, with 
error bars indicating the SEM. Ratios >1 indicate greater perfusion in IACFM-treated 
hindlimbs. * p<0.05, as determined by single sample t-tests with a population mean 
of 1. 
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3.3.2 Morphology of the microvasculature 
 
A representative micro-CT image of the microvasculature morphology in the 
healing MCL and surrounding connective tissue is shown in Figure 3.4. There were no 
significant differences in VV/TV, V.Th, V.N or V.Sp between IACFM- and non-treated 
hindlimbs (all p=0.37 to 0.90) (Figure 3.5A, B, C). IACFM-treated hindlimbs had a higher 
proportion of blood vessel diameters, i.e. distribution of V.Th, within the 17.7 to <29.4 µm 
range compared to non-treated hindlimbs (p=0.02) in the tibial subregion (Figure 3.6A). 
There were no differences in the distribution of V.Th between IACFM- and non-treated 
hindlimbs in the femoral and middle subregions (all p>0.05) (Figure 3.6B, C). 
 
 
 
 
Figure 3.4. Representative micro-CT image of the microvasculature 
morphology in healing MCL and surrounding connective tissue.  Blood vessels 
(shown in red) are distinguishable since they have been filled with radiopaque 
contrast agent.  Connective tissue is radio-transparent at the blood vessel 
threshold and is not visible in this image. 
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Figure 3.5. Microvasculature morphometric parameters in IACFM- and 
non-treated hindlimbs. There were no significant differences in A)  
vessel volume normalized to tissue volume (VV/TV), B) vessel 
thickness, a.k.a. vessel diameter (V.Th), and C) vessel number between 
IACFM- and non-treated hindlimbs (all p=0.37 to 0.90). 
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Figure 3.6. Frequency distribution of vessel thickness 
(diameter) in ligament subregions. A) IACFM-treated 
hindlimbs had a higher proportion of vessel diameters 
(vessel thickness [V.Th]) within the 17.7 to <29.4 µm 
range compared to non-treated hindlimbs (*p=0.02) in the 
tibial subregion. No differences were found in the 
distribution of vessel diameters between IACFM- and 
non-treated hindlimbs in the B) middle or C) femoral 
subregions (all p>0.05). 
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Tibial 
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3.4 Discussion 
 
Initial studies in this dissertation demonstrated IACFM accelerated the return of 
mechanical and histological properties following acute ligament injury. Since each phase 
of ligament healing requires adequate blood supply it was thought that IACFM-induced 
alterations in vascular properties were likely mechanisms underlying these preliminary 
findings.  
Increased regional blood flow was found in IACFM-treated injured knee 
ligaments as compared to untreated contralateral injured ligaments; however, the 
increase was not observed immediately following intervention. This finding suggests 
IACFM does not lead to a direct increase in tissue perfusion due to vasodilation. Instead, 
IACFM-treated hindlimbs revealed increased tissue perfusion 24 hours following 
treatment sessions which persisted for 1 week following the last treatment. These 
findings suggested IACFM may stimulate angiogenesis when repeated applications are 
delivered over time.  
Subsequent micro-CT analysis revealed a significant increase in smaller 
diameter blood vessels in the tibial portion of the IACFM-treated ligaments. Interestingly, 
this study found an increase in small blood vessels in the diameter range of arterioles. 
This is significant in that arterioles regulate blood flow through the capillary beds that 
they supply.28, 166 Notably, the vascular expansion was only found in the tibial portion of 
the ligament. Given the definitive increase in regional blood blow, the investigators 
expected all portions of the ligament would have demonstrated increased angiogenesis. 
It is possible IACFM-treated vessels were relatively more dilated while in living tissue 
compared to those in untreated tissues indicating a greater functional response versus a 
structural change. Or, possibly, the regional variation could be related to normal vascular 
anatomy of the region or transitional zone characteristics at the MCL tibial insertion 
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(Chapter One). Another likely factor could be varying treatment pressures in different 
subregions of the ligament. For example, greater pressure may have been generated in 
the tibial portion due to direct compression of the ligament between the rigid treatment 
device and the underlying bone. This would correspond to findings in a prior study that 
demonstrated higher fibroblastic activity in IASTM-treated tendons in response to higher 
pressures.158   
LDI was used to measure regional blood flow. Other authors have exposed the 
MCL to obtain measures more specific to the MCL;77 however, exposing the MCL would 
not have allowed for multiple in vivo measures over time in response to repeat IACFM 
interventions as commonly performed in the clinic. Furthermore, IACFM intervention is 
clinically delivered through the skin, affecting many tissues.  
Micro-CT imaging was used ex vivo to assess blood vessel morphological 
parameters in response to IACFM intervention. The ligament proper and surrounding 
connective tissue of a standardized sample size was analyzed for morphological 
vascular parameters of a selected VOI. This approach was chosen since ligaments are 
relatively avascular and rely on surrounding connective tissue for blood supply as 
described in Chapter One, section 1.6.1. This research study was able to resolve 
vessels down to 5.9 μm diameter, which is consistent with other investigations.92,83  
In conclusion, IACFM significantly increased tissue perfusion over time. 
Furthermore, a significant increase in smaller diameter blood vessels in the distal portion 
of IACFM-treated ligaments was found. These findings suggest improved vascular 
properties may be a factor underlying the accelerated IACFM-treated knee ligament 
healing previously demonstrated. Mechanotransduction of the IACFM treatment forces is  
a possible mechanism for the enhanced biomechanical, histological and vascular 
properties found in IACFM-treated healing knee ligaments throughout this research 
program.   
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CHAPTER FOUR 
Mechanotransduction as a Mechanism for the Therapeutic Effects of                               
Instrument-Assisted Cross Fiber Massage 
 
4.1 Introduction 
 
Preliminary studies in this dissertation suggest CFM, specifically IACFM, has 
beneficial effects on biomechanical, histological and vascular properties in healing knee 
ligaments in rats (Chapters Two and Three). Positive effects of CFM and IACFM have 
been previously reported in animal model and clinical studies (Chapter One). Mechanical 
forces influence the growth and shape of virtually every tissue and organ. It is known 
that cells are mechanosensitive to their surrounding environment and that physical 
forces play an important role in the organization, growth, maturation and function of 
tissues.167 It follows that an essential mechanism underlying the therapeutic effects of 
CFM, and arguably all forms of STM, may be mechanotransduction.   
Mechanotransduction is defined as processes whereby a mechanical stimulus is 
converted into biochemical responses that affect cellular functions.168-169 It is involved in 
homeostasis, and tissue healing and repair, and implicated in some disease processes 
such as vascular atherogenesis.170 Load signaling pathways have been considered with 
multiple tissues, e.g. bone,168, 171-172 tendon,173 cartilage,174 ligament,175 and intervertebral 
discs.176 Mechanotransduction has been implicated as a mechanism for the treatment 
effects of modalities such as low intensity pulsed ultrasound in bone177 and ligament 
healing;22 acupuncture;178-179 therapeutic exercise180 in tendon, muscle,181 and bone;182 
and functional activities.183 Nonetheless, there is still much to learn about the 
mechanisms by which individual cells sense mechanical signals and transduce them into 
intracellular biochemical responses and gene expression. 
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Manual therapy interventions offer conservative treatment alternatives to invasive 
procedures and pharmaceuticals. A common denominator for all STM approaches is that 
they exert a physical force on the soft tissue which may be detected and converted into 
a signal with downstream effects on the ECM, vascular function and structure, 
neurosensory system, and the tissue healing and repair process. This purpose of this 
chapter is to introduce the concept of mechanotransduction as a mechanism for the 
therapeutic effects of CFM, whether administered by hand or instrument-assisted. 
 
4.2 Background on tissue adaptation models 
 
The concept of load-signaling pathways is not new. Wolff‘s law (Julius Wolff, 
1892) predicted that remodeling of bone occurs in response to physical stresses. This 
model led to a later concept that bone is deposited in sites subjected to stress and 
reabsorbed from sites with minimal stress; essentially, it asserts mechanical stress is 
responsible for determining the architecture of bone.184 The piezoelectric effect, i.e. the 
ability of some materials to generate an electric potential in response to applied 
mechanical stress, was used to explain this relationship between the structure and 
function in bone. Davis‘ law is the connective tissue corollary of Wolff‘s law that 
describes how soft tissue models along imposed demands.184   
The mechanostat theory, introduced by Frost in the 1980s, depicts the 
modulation of bone modeling or remodeling by mechanical strain. It is therapeutically 
useful in that it suggests a window of optimal load for signaling a physiological 
response.172 The concept of tensegrity (Fuller, 1965) offers a model of cell architecture 
that helps explain how the mechanical behavior of the cell emerges from physical 
interactions among different molecular filament systems forming the cytoskeleton and 
the nucleus. The model contends cell tensile elements (actin filaments) impose a pre-
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stress on cells that is countered by compression-resistive elements (microtubules).185-187 
More recent literature describes the concept of mechanotransduction.  
 
4.3 Mechanotransduction 
 
Mechanotransduction is defined as the process of mechanical forces influencing 
intracellular signaling and subsequent cell behaviors. It involves a four-stage cell-
mediated theory including mechanocoupling, biochemical coupling, signal transmission 
and effector response, summarized in Table 4.1.169, 182   
 
Table 4.1 Summary of stages in mechanotransduction process  
Mechanocoupling Physical transduction of loads (mechanical force) applied to 
tissue into local mechanical signals that can be detected by 
tissue cells. Involves physical derangement or perturbation of the 
cell, either directly or indirectly. 
 
Biochemical coupling Process whereby the local mechanical signal is converted into a 
biochemical signal.  Cells sense a load using mechanosensitive 
structures.   
 
Signal transmission Process in which a sensor cell signals an effector cell.  
 
Effector response Cellular outcomes that may lead to protein synthesis, remodeling 
and reabsorption of its matrix.  Leads to a tissue level response.  
 
 
 
4.3.1 Mechanocoupling 
 
Mechanocoupling is the physical transduction of mechanical force to a form that 
can be detected by cells. For example, in connective tissue, mechanical loads (stress) 
imposed by movement cause local deformations (strain) in the ECM detected by a 
sensor cell. Fibroblasts are sensor cells in connective tissue. The transduction of 
mechanical forces to a signal the cell can detect is effected by the rate, magnitude and 
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frequency of the applied load.169, 188 For example, one study using IASTM on injured rat 
Achilles tendons found fibroblast proliferation depended on the magnitude of applied 
pressure.158 
Fluid shear, compression and tension (stretch) stresses from the surrounding 
environment are stimuli for mechanical signaling in cells. Experiments involving 
mechanical stress on cells have been done mostly on cultured fibroblast, endothelial and 
smooth muscle cells using either cyclic stretch or prolonged shear.97, 121, 189 Results of 
studies have shown tensile stress imposed on fibroblasts in static culture causes actin 
filaments to reorganize from an irregular orientation to organized bundles (―stress fibers‖) 
associating with focal adhesions (FAs) without significant change in tubulin or 
intermediate fibers.190 Other studies have found that fluid flow creates shear stress on 
cell membranes which induces rapid release of prostaglandins, e.g. PGE2, PGI2. These 
particular prostaglandins can alter fluid viscosity to a more serous-like consistency which 
facilitates cell migration.191 Once the mechanical stimulus is detected by the cell, it is 
translated by mechanosensors it into a cellular response. 
 
4.3.2 Biochemical coupling 
 
Biochemical coupling is defined as the transduction of a local mechanical signal 
into an intracellular biochemical response ultimately leading to gene expression. 
Mechanical signaling is transduced into a biochemical response through at least four 
independent but interacting mechanosensors: a) integrins, b) stretch activated calcium 
(Ca++) channel opening, c) G-protein activation in the lipid bilayer, or d) cytoskeleton 
deformation; and as of yet, unidentified mechanoreceptors. Although the processes are 
complex and not fully understood, it is known that a broad range of mechanical stimuli 
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can act through divergent or common signaling pathways. The desired gene expression 
is achieved by the integration of direct and indirect processes.97  
a) Direct processes in mechantransduction 
 Deformations of the ECM can have a direct effect on the translation of a 
mechanical stimulus into a cellular response through the ECM-integrin-cytoskeleton axis. 
Load-signaling pathways in connective tissues typically involve different types of cell 
matrix adhesion contacts, e.g. FAs. Integrins are cell surface receptors that associate 
with FAs to create a transmembrane axis that physically couples the ECM with 
cytoplasmic constituents to transmit external stimuli directly to the internal environment 
of the cell.97 Integrins are transmembrane glycoproteins with α and β subunits that bind 
specifically to ECM proteins (e.g. fibronectin, collagen); and, intracellularly with the 
cytoskeleton and other cytoplasmic components via adapter structural proteins (e.g. 
vinculin, talin, zyxin, paxillin).190 It is thought that integrins within FAs function primarily 
as stretch sensors (‗strain gauges‘) that trigger downstream signaling pathways in 
response to changes in mechanical stress, i.e. reorganization of cytoskeletal 
components, redistribution of intracellular forces.97  
The cytoskeleton filament network in turn has physical connections to the 
nucleoplasmic surface. The nuclear membrane is connected to nuclear scaffolds that 
may connect to discrete DNA regions which can directly alter gene transcription.192 The 
exact nature of this process remains unknown; however, there is evidence for 
mechanical coupling between the cell surface and nucleus enabling the entire cell to 
function as a single, mechanically-coupled system. For example, mechanical forces 
promote structural rearrangements within the cytoplasm and nucleus that allow for faster 
conduction of events than chemical diffusion or translocation based signal propagation, 
in the order of milliseconds compared to seconds respectively.190  
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b) Indirect processes in mechantransduction 
The translation of mechanical stimuli by sensor cells may be indirect, involving 
various intracellular signaling cascades. One prominent signaling cascade is stretch 
activated ion channel opening. For instance, stretch activated Ca++ channel opening 
allows an influx of Ca++ which activates Ca++-dependent signaling paths. Alternatively, a 
cellular mechanotransduction pathway could activate an available transcription factor, or 
induce its transcription, which then binds to a regulator element in an ECM gene 
promoter.33, 97  
 
4.3.3 Signal transmission  
 
The biochemical signal in the sensor cell can be propagated to an effector cell 
via two pathways. First, a fibroblast can sense the mechanical deformation and the 
same cell acts as the effector cell leading to increased synthesis of ECM components. 
This may occur by direct upregulation of synthesis of matrix products (i.e. tenascin-C, an 
anti-adhesion molecule) or autocrine mechanisms such as synthesis of growth factors 
that act on the sensor cell itself. Secondly, intercellular signaling may be propagated 
from a sensor cell to other effector cells via cell-cell communication (i.e. via gap 
junctions) or by paracrine mechanisms, including growth factors (e.g. TGF-β) or 
signaling molecules (e.g. nitric oxide [NO], prostaglandins), that act on surrounding 
cells.33  
 
4.3.4 Effector response   
 
The effector cell response is the cellular outcome that leads to the final tissue-
level response. Downstream effects of a mechanical stimulus may include synthesis and 
70 
 
local release of growth factor, cytokines, vasoactive substances, degradative enzymes 
and structural matrix elements.182  
A combination of complex processes mediates the integration of chemical and 
physical signals responsible for the control of cell behavior and tissue properties. The 
exact nature of these processes remains a matter of ongoing investigations. It‘s 
plausible that IACFM exerts a physical force that has downstream effects on the 
connective tissue matrix, vascular function and structure, and neuromodulation which 
deserve consideration. 
 
4.4 Mechanotransduction and the connective tissue matrix  
 
 The improved biomechanical and histological properties demonstrated during 
early healing in IACFM-treated knee ligaments in this dissertation possibly reflect the 
mechanotransduction of the IACFM stimulus into cellular responses leading to 
alterations of the connective tissue matrix. A probable mechanotransduction pathway for 
the effect of IACFM on the connective tissue matrix is the ECM-integrin-cytoskeletal axis 
previously described in section 4.3.3.a. Figure 4.1 illustrates a simplified sequence for a 
clinical perspective of a possible direct signaling cascade in response to this form of 
IASTM. In this scenario, the cascade is initiated when a rigid instrument is used to apply 
a mechanical load (stress) to the body surface which generates deformations (strain) in 
the ECM of underlying soft tissue. The physical force is then transduced by integrins in 
the plasmalemma into an intracellular response. The signal is subsequently transmitted 
through the cytoskeleton filaments to the nucleolemma and nuclear scaffold which may 
upregulate gene expression. This could result in increased mRNA levels, translation and 
protein synthesis culminating in altered cell function and tissue-level response.190 
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Each step of the described mechanotransduction process as it relates to a CFM 
force requires further substantiation, and provides a level of inquiry for future 
investigations on the effects of manual therapies in normal and injured tissue. For 
example, at the level of mechanocoupling, studies could explore the effects of stress (i.e. 
magnitude, rate, duration, direction, type) from CFM. The type of stress interpreted at 
the cell surface may be tensile, compressive or shear in nature. Biochemical processes 
triggered by CFM stimulation including signaling pathways, gene expression (i.e. mRNA 
levels) and protein levels (i.e. of transcription factors) and signal transmission processes 
involving levels of growth factors and signaling molecules involved in could be 
determined. The effector response could be analyzed by monitoring changes in cell 
activity and ECM composition, e.g. proliferation, tenascin-C or collagen levels, in 
response to IACFM treatment. 
IACFM may affect FA formation. The mechanical link between FAs and the 
surrounding ECM and cytoskeleton allows bidirectional communication between the 
inside and outside of cells.192-193 It is the transmission of load through FAs that controls 
their maturation (i.e. size) or disassembly. In fact, the size of FAs has been found nearly 
proportional to the local mechanical stress to which they are subjected.97, 194 In order to 
provide additional insight into mechanotransduction processes and the connective tissue 
response to non-invasive physical forces, future studies could aim at establishing the 
effects of various manual therapy applications such as IACFM on FA size (maturation), 
specific connections of FAs with the ECM or cytoskeletal components, alterations in 
proteins associated with FAs, and consequent cytoskeletal organization.   
As a final consideration, it is known that the 3D composition of the ECM is 
adapted specifically to changes in load (i.e. fiber alignment, fiber size, interfiber distance, 
cross-linking). Interestingly, studies have found when the 3D ECM is compressed (as 
into a sheet) or has increased cross-linking; a rigid versus porous ECM is produced that 
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alters distribution of adhesion proteins.192, 194 The 3D ECM composition in response to 
IACFM should be explored since connective tissue manipulation may help to restore its 
architecture to one more conducive of functional mobility and strength.  
 
4.5 Mechanotransduction and vascular function and morphology 
 
Studies in this dissertation also demonstrated positive vascular effects of IACFM 
in healing knee ligaments. It is conceivable that the intermittent force from CFM 
intervention may load vascular tissue directly or through tension in the ECM, or may alter 
fluid flow (i.e. rate, impulse) in a manner that facilitates vascular function and growth.   
Oxygen levels, circumferential stretch from blood pressure impulses, shear 
stress from blood flow, and a variety of growth factors are among stimuli that regulate 
vessel growth and remodeling. The primary trigger for adult angiogenesis is tissue 
ischemia; however, flow-mediated mechanotransduction from shear stress has a 
profound effect on the functional expression of endothelial cell (EC) and vascular smooth 
muscle cell (VSMC) proteins, including transcription factors, enzymes, growth factors, 
signaling molecules, integrins and adhesion molecules.68 Blood pressure impulses 
cause circumferential stretching to ECs and VSMCs, while shear stress from flowing 
blood acts on ECs lining the vessels. ECs do respond to stretch, but shear seems to be 
a main determinant of EC function.  
As in fibroblasts, a number of mechanosensors in ECs and VSMCs have been 
proposed to mediate load signaling pathways in vascular tissue. Forces are typically 
transmitted in ECs from the apical cell domain (where shear is applied) through the 
cytoskeleton to basolateral domains (where integrins exist that interact with the ECM).  
Subsequent changes in classic signaling pathways and multiple transcription factors 
mediate the response of ECs and VSMC to changes in flow and stretch. For instance, 
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flow-mediated mechanotransduction may lead to NO release resulting in vessel 
dilation.68 This provides a plausible explanation for the enhanced tissue perfusion 
despite the modest degree of angiogenesis found in IACFM-treated knees in this 
dissertation; although, future study is required. 
Shear is a key determinant of EC function; however, there is evidence 
suggesting a reciprocal relation between the ECM and EC activity. For instance, the 
ECM can modulate how flow-sensitive ECs respond to this force during matrix 
remodeling. The ECM provides a scaffold through which new vessels migrate. The ECM 
helps regulate angiogenesis, in part by modulating normal integrin receptor expression 
and ECM-endothelial cell interactions, although the details are not fully understood.170 
Mechanical stimulus may also be a factor in mast cell degranulation, macrophage 
recruitment and endothelial cell migration; all of which are essential for directing tissue 
vascularization.67-68 Future inquiries on EC and/or VSMC cellular activity in response 
IACFM stimulation may provide insight into the mechanisms underlying the beneficial 
effects of this modality. 
 
4.6 Mechanotransduction and neuromodulation  
 
The neurological effects of IACFM were not addressed in this dissertation; 
however, it is logical that this manual therapy could impact neurosensory and 
neuromuscular processes. Ligament innervation has been implicated for normal 
ligament healing and function. For instance, one study showed denervation of rabbit 
MCLs impaired healing.195 Comparatively, another study revealed injured rat MCLs 
treated directly with exogenous nerve growth factor had increased nerve density and 
improved biomechanical properties.164  
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Neurosensory stimulation provides information to an organism about its external 
and internal environment, and facilitates reflexive modulation of organs, systems and 
immune effector functions. Mechanosenory cells respond to physical forces (e.g. sound, 
touch, joint motion, and muscle, tendon, and capsule stretch receptors) and transmit a 
facilitory or inhibitory response. Each sensor cell has distinct cytoskeletal elements and 
extracellular components. Sensory mechanoreceptors have different structures but all 
have transduction channel proteins which are not yet well characterized.196 
Neurosensory transduction is thought to result primarily from the direct gating of 
transduction channels. In excitable cells, (mechanosenory nerve and muscle cells), 
stretch sensitive cation channels (i.e. mechanically gated of K+ channels) are more likely 
to act as strain gauges than integrins as in connective tissue.197  
It is questionable whether the neuromodulatory effects of CFM techniques are 
facilitory or inhibitory. A recent study found CFM reduced the excitability of the flexor 
carpi radialis motor neuron pool.151 Other studies have shown massage of the forearm 
and hand to improve motor performance including increased power grip strength 
following exercise fatigue.147  
Analgesia is a reported benefit of CFM interventions. Most often CFM is not 
painless for a patient to receive. Apparently, CFM provides a form of counter-irritation 
(noxious stimulation) for pain modulation that leads to an analgesic response. Blocked 
nocioception due to inhibition of pain signals via the gate-control mechanism is a 
possible mechanism for the analgesic effects of IACFM.198-199 Reduced pain can lead to 
muscle relaxation which allows for more normal neuromuscular movement patterns and 
functional progression.200 
IACFM may influence the ANS, perhaps indirectly, i.e. via pain reduction.  
Autonomic nervous system (ANS) effects have been implicated as an underlying 
mechanism for some manual therapies, e.g. eliciting a shift from a sympathetic state to a 
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more parasympathetic response. Pressure applied by massage approaches may 
stimulate vagal activity, reduce stress hormones and decrease arousal leading to 
increased parasympathetic activity (e.g. decreased heart rate, blood pressure, 
respiratory rate).123, 201  
The neuromusculoskeletal system requires adequate neuromodulation for full, 
pain-free function to occur normally and during tissue healing and repair. More research 
on the effects of mechanical soft tissue manipulation on neurosensory and 
neuromuscular modulation including pain, muscle performance, and ANS response is 
indicated. 
In summary, mechanotransduction is a mechanism for CFM approaches to affect 
the neuromusculoskeletal and vascular systems with consequent clinical implications. 
Several perspectives must be considered in the decision to utilize manual therapy 
interventions clinically. 
 
4.7 Clinical perspectives on mechanotransduction and IACFM 
 
Manual therapies involve the application of specifically selected forces directed to 
the body tissues to induce desired outcomes. The concept of mechanotherapy was 
recently re-introduced with respect to therapeutic exercise as ―the employment of 
mechanotransduction for the stimulation of tissue and repair.‖180 IACFM is a form of 
mechanotherapy; however, the rationale to use it, or any soft tissue manipulation 
technique, depends on several factors, e.g. the stage of tissue healing and repair (acute 
vs. chronic). For example, IACFM should not be used acutely in a manner that would 
interrupt the healing process; but on the other hand, it should be introduced early 
enough to avoid the formation of covalent cross-links in newly deposited, disorganized 
collagen fibers. Overall patient condition (i.e. co-morbidities), associated pathology, 
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tissue structure and type and the desired treatment response (i.e. pro-inflammatory vs. 
non-inflammatory) must also be considered.144-145    
In practice, manual therapy treatment parameters (e.g. load frequency, rate, 
direction and duration) are adjusted to deliver a mechanical stimulus to the tissue in 
order to elicit a desired response (e.g. decreased pain; increased strength, mobility, 
function). For instance, IACFM is often used more aggressively (i.e. higher load with 
chronic, degenerative conditions such as tendinosis,) reportedly to introduce a controlled 
amount of micro-trauma to the tissue in order to re-initiate the healing cascade. On the 
other hand, it is suggested IACFM be used less aggressively (i.e. lower load) in the case 
of an acute tendinitis for the purposes of desensitization and preventing adhesions 
formation.144-145   
Guidelines for manual therapy applications are founded mostly in clinical 
observations and physiological rationale which require validation. The theory behind 
many approaches rests on how the pressure is applied. Although one animal study 
examined the effects of varying massage pressures,158 human subjects studies have not 
considered this variable.201 Complex models of soft tissue mechanics have been 
developed; however, a conceptual framework for STM approaches based on the 
mechanotransduction of the mechanical stimulus that typifies a given technique would 
be advantageous for establishing practice guidelines.  
A framework for STM approaches can be imagined that would classify 
techniques based on the nature of their mechanical stimulus in context of the desired 
response. The mechanical stimulus could be initially defined by its load (i.e. high vs. low 
load) and frequency (i.e. high vs. low frequency). Formulating such a framework would 
require future effort, including dose response studies. One of the first challenges would 
be to quantifiably define high versus low load and frequency. 
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A conceptual framework of STM approaches based on the mechanical stimulus, 
possible indications and potentially desired treatment response is outlined in Table 
4.2.30, 115, 145, 202 The framework in Table 4.2 is not meant to be exhaustive, but it is 
presented for illustrative purposes. Other treatment parameters should eventually be 
integrated and a greater variety of manual approaches could be included to develop a 
more comprehensive framework. Such a structure would help to establish a common 
perspective for clinical utility in selecting and evaluating different manual therapies for 
various conditions. It would also facilitate the design of research projects aimed at 
establishing optimal dose responses for different techniques, comparing manual therapy 
approaches to each other or other modalities, and evaluating the summative effects of 
physical interventions, e.g. the effects of therapeutic exercise and massage on tissue 
healing.  
 
In conclusion, mechanotransduction is a proposed mechanism for the beneficial 
effects of IACFM, a form of manual therapy, demonstrated in this dissertation. A greater 
understanding of how a manually delivered mechanical stimulus is transduced into a 
therapeutic response will foster improved therapeutic outcomes. Better characterization 
of STM approaches based on the mechanical stimulus delivered to the tissue will 
support research and clinical decision making processes.    
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CHAPTER FIVE 
Summary and Future Directions 
 
 
5.1 Dissertation summary 
 
Studies in this dissertation investigated the effects of IACFM on knee MCL 
healing using an established rodent model. Initial studies found that IACFM-treated 
injured ligaments, have a) enhanced mechanical properties at 4 weeks post-injury, 
suggesting accelerated healing, and b) improved stiffness at 12 weeks post-injury, 
possibly indicating augmented healing compared to contralateral untreated, injured 
ligaments. Light microscopy revealed qualitative improvements in fibroblast proliferation 
and fiber alignment. Subsequent SEM observations confirmed the latter. Histological 
findings may be related to the improved healing found in IACFM-treated ligaments. 
Succeeding studies considered vascular properties in IACFM-treated versus 
untreated healing knee ligaments in rats. LDI assessment revealed enhanced regional 
blood flow over time with repeated IACFM application. Subsequent micro-CT analysis 
found regional alterations in microvasculature structure possibly suggesting 
angiogenesis. These vascular findings may be related to the accelerated healing found 
in IACFM-treated ligaments.  
Mechanotransduction was proposed in concept as a mechanism for the 
therapeutic effects of IACFM found in this research project. Factors involving 
mechanotransduction and the connective tissue matrix, vasculature and 
neuromodulation were considered in greater detail, and clinical implications discussed. 
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5.2 Strengths and limitations of the present research project 
 
There are noteworthy strengths of studies in this dissertation. First, findings from 
this research program help to fill a void in the literature regarding the effects of manual 
therapy interventions. Irrespective of the longevity and popularity of its use for a variety 
of conditions, relatively little quantitative research on the benefits of massage techniques 
has been performed. Studies in this dissertation demonstrated quantitative 
improvements on a tissue-level in the biomechanical and vascular properties of healing 
knee ligaments using a type of massage, IACFM. This is important, because manual 
therapies, including IACFM, offer readily available and cost-effective alternatives to 
invasive (i.e. surgical) and possibly toxic interventions (i.e. pharmaceuticals) in the 
management of musculoskeletal disorders. Secondly, the research that has been done 
on manual therapies is limited not only in quantity but quality.123, 201 Thus, another 
primary strength is the experimental design of studies in this research project. The use 
of a within-subject study design enabled more accurate investigation of IACFM tissue-
level effects. By comparing IACFM-treated versus contralateral untreated injured MCLs 
in the same subject, it helped to control for potential confounding effects of other 
variables, e.g. activity levels, treatment pressure, genetic and environmental factors. 
In light of its strengths, there are acknowledged limitations with studies in this 
dissertation. First, studies were performed in an animal model wherein the knee MCL 
was injured via surgical transection. Although this is a highly reproducible and 
established model for the preclinical testing of ligament injuries,7, 14, 49, 203 the ability of the 
model to predict the clinical scenario wherein ligaments are injured via excessive tensile 
load has not been established. Second, the size of rodent tissues in relation to those of 
humans raises scaling issues in terms of intervention introduction and response. This 
issue was addressed by introducing IACFM to rodent ligaments with the same tool and 
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force as used clinically to treat similarly sized ligaments. Using a pressure sensor could 
have standardized the pressure given; however, this was controlled for by a single 
individual administering the treatment. Third, between-animal differences in activity 
levels may have influenced ligament healing rates as activity has previously been shown 
to mediate healing of isolated connective injuries in rodents.158, 204 Again, these variables 
were controlled for by establishing IACFM effects within-animal design. Fourth, the 
current studies did not consider IACFM effects on clinically-measurable outcomes such 
as recovery from symptoms (e.g. pain, fatigue) which can influence function. The 
restoration of mechanical and vascular properties are important preclinical outcomes; 
however, it is feasible that IACFM can affect tissue-level properties without influencing 
symptom recovery. Despite these limitations, IACFM-treated knee ligaments 
demonstrated improvements in mechanical, histological and vascular properties. 
Adequate ligament strength is needed for ligament function, and adequate perfusion is 
essential to all stages of ligament healing; however, many questions remain. 
 
5.3 Future directions  
 
 This research program found positive effects of IACFM in healing knee ligaments 
on a tissue level in rats; however, future is study is needed to further substantiate its 
mechanisms and benefits. Research projects could aim to establish the effects of IACFM 
treatment on connective tissue matrix characteristics and associated cellular and 
molecular-level events, vascular properties and clinical outcomes. 
 Future research projects that establish the effects of IACFM treatment on 
characteristics of the connective tissue matrix that modulate tissue tensile strength and 
stiffness are indicated. In order to have such effects, IACFM must influence the 
fibroblastic cells responsible for producing collagen. A candidate pathway for 
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investigation at each level of the mechanotransduction process is the ECM-integrin-
cytoskeleton axis as discussed in Chapter Four. In brief, studies considering the tissue-
level effects of IACFM may include analysis of collagen content (e.g. total collagen, 
relative proportions of collagen type I and type III), non-collagenous content (e.g. 
proteoglycans), and fibril diameter and alignment. The degree of mature, non-reducible 
collagen cross-link content (e.g. hydroxlysyl pyridinoline) could also be analyzed.38  
Investigations on the cellular and molecular-level events in response to IACFM 
stimulation may consider DNA content, mRNA expression of candidate genes 
responsible for the observed tissue-level effects (e.g. gene expression for collagens, 
proteoglycans, growth factors, collagenases), protein levels and localization including 
focal adhesion localization and maturation. 
Additional research is needed to further resolve the effects of IACFM on ligament 
vascular properties. For instance, other methods, which may be more precise, e.g. laser 
speckle imaging, could be used to determine alterations in blood flow in response to soft 
tissue manipulation techniques.205-206 Also, future studies may use other contrast 
mediums and imaging methods to determine vascular volume, and could consider 
measuring vascular morphological parameters of the ligament proper only.66, 85-87 
Studies investigating cellular and molecular mechanisms underlying vascular function in 
response to IACFM treatment are also needed. Atypical ligament cell populations may 
be assessed, especially those that produce angiogenic factors associated with ligament 
injury, e.g. mast cells207 or macrophages;208-209 or peri-endothelial cells. These cell 
populations are mediated by a variety of factors and express an array of vasoactive 
peptides, growth factors and cytokines. Gene expression of angiogenic factors and their 
receptors (i.e. VEGF, VEGFR, Ang-1, FGF, PDGF-β, TGF-β) at the transcript level38 
along with resultant protein levels and localization of angiogenic factors should be 
examined. The role of the ECM in angiogenesis in response to IACFM treatment is 
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another avenue for future investigation, since it provides a scaffold through which new 
vessels migrate. The ECM also regulates angiogenesis in part by modulating integrin 
expression and ECM-endothelial cell interactions.68  
Research from a more clinical perspective is warranted. The load and frequency 
used in this research program were based on clinical recommendations for IACFM 
application to a structure of similar size; however, dose response studies are needed. 
Future research should aim to establish the effects of IACFM force magnitude, 
frequency and duration on connective tissue. For example, one study in this dissertation 
found IACFM ligaments to have enhanced stiffness at 12 weeks post-injury indicating 
IACFM may augment ligament healing; however this time period appeared too short to 
establish whether the final product of the ligament healing process is enhanced with this 
intervention. To demonstrate more conclusively whether IACFM augments ligament 
healing, longer-term effects (i.e. 6 months post-injury) should be investigated. A discrete 
treatment modality (i.e. IACFM) and a dense, regular connective tissue type (i.e. 
ligament) were focused on for experimental control; however, studies could consider 
other forms of STM and tissue types. Moreover, the combined effects of other 
modalities, e.g. exercise, and IACFM should also be explored. Finally, clinical trials are 
needed to establish the therapeutic effects of IACFM on pain, impairment and function in 
human subjects. 
In conclusion, this dissertation provides insight into the beneficial effects of a 
manual therapy intervention, IACFM, on ligament healing using an animal model. These 
findings are compelling given the current healthcare climate which demands evidence-
based practice and reduced costs in an aging population. As essential mechanisms 
underlying the effects of soft tissue manipulation are better understood, a greater 
potential for manual therapies in the conservative management of connective tissue 
dysfunctions can be derived. 
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